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CHAPTER I 
 
INTRODUCTION 
      
In most developing countries, malaria stills an important public health issue. Its global 
burden and economic costs are still enormous, and causes about 225 million cases 
resulted in 781 000 deaths in 2009 (WHO, 2010). 
 
 In Malaysia, the fight against malaria, which began more than a hundred years 
ago, specifically in 1901, led to an impressive decrease in the disease prevalence from 
about 300,000 to 7000 reported cases in 2009 (WHO, 2010).
 
However, a sudden 
increase in the incidence of malaria has been reported in 2008 and this may call for an 
urgent update to the means of eliminating the disease (Kaur, 2009). 
 
Even though indoor 
residual spraying of insecticides is a good method for malaria control in Malaysia 
(Rohani et al., 2006), elimination of malaria from a community requires combining 
several measures for the implementation of that strategy. The 1998 Roll Back Malaria 
(RBM) programme, launched in Geneva by WHO, UNDP, UNICEF and the World 
Bank, is a people oriented plan that emphasises community involvement (WHO, 1998; 
Udonwa et al., 2010).  
 
 
 
 
 2 
 
 The participation of the community represents one cardinal tool of malaria 
control programmes by the WHO as the improvement of understanding of transmission 
of malaria can greatly increase the realization and sustainability of malaria elimination 
programme (Nchinda, 1998; Govere et al., 2000; Hlongwana et al., 2009). 
 
 Evidence of artemisinin-resistant malaria has been reported on the Thai-
Cambodian border and there is a global call to look for new anti-malarial agents from 
medicinal plants, which represent the main ingredients of modern anti-malarial agents 
(Htut, 2009). The new drugs must exhibit efficacy and safety, be inexpensive and have 
additional properties important for the specific disease indication (Rosenthal, 2003).  
 
 Consistent with this specification, traditional medicinal plants have several 
potential advantages; they are affordable, easily accessible and there is no evidence of 
resistance to whole-plant extracts. Moreover, traditional plants have been utilized to 
cure malaria for hundreds of years and provided the human with the basic components 
of the main malaria treatments used in the present age; artemisinin and quinine 
derivatives (Willcox & Bodeker, 2004; Batista et al., 2009). Medicinal plants may 
provide anti-malarial drugs directly, as in the case for quinine from cinchona bark, or 
they may supply template molecules on which to base farther new structures by organic 
synthesis—artemisinin from Artemisia annua.  
 
 Although many communities have achieved successful ethnobotanical 
approaches in fighting malaria, very little is known about plant remedies preparation 
that are remain employed in the treatment of malaria in Peninsular Malaysia. The 
ethnobotanical approach to the search for novel anti-malarials from plant products has 
confirmed to be more prognostic compared to the random screening approach, where 
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the most important modern anti-malarial drugs are derived from the medicinal plants 
known to have ethnomedical standing (Saxena et al., 2003).  
 
 In parallel with the implementation of Malaysia's malaria elimination 
programme, this study was carried out to evaluate the community‘s awareness regarding 
malaria transmission, treatment and vector control between the aboriginal and rural 
communities in district of Lipis, Pahang state, which still represents one of the highest 
prevalence of malaria cases in Peninsular Malaysia. The present study was also carried 
out to establish a preliminary ethnobotanical database for the plants traditionally used to 
treat malaria.  
 
 In vivo anti-malarial activity of four plant species, namely, Cocos nucifera L. 
Labisia pumila (Bl.) F.-Vill., Languas galanga Stuntz. and Piper betle L. selected based 
on the ethnobotanical survey and literature were evaluated against laboratory malaria 
model Plasmodium berghei to evaluate their anti-malarial activity. The acute oral 
toxicity (LD50) was established to determine the safety of the plants extract. The 
phytochemical and antioxidant potentials of the crude extracts were also investigated to 
elucidate the possibilities of its anti-malarial effects.  
 
 
1.1  OBJECTIVES OF THE STUDY 
 
1.1.1 General Objectives: 
 
1. To investigate the household knowledge, attitude and practices (KAP) regarding 
malaria in two malaria endemic communities, forest-aboriginal and rural 
communities, in the Lipis district of Pahang state, Malaysia. 
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2. To investigate the plants traditionally used in the treatment of malaria in the two 
malaria endemic communities of the forest-aboriginal and the rural 
communities, and traditional healers. 
 
3. To evaluate the in vivo anti-malarial activities of selected medicinal plants 
traditionally used by the Malaysian people to treat malaria. 
 
1.1.2 Specific Objectives: 
 
1. To compare the awareness regarding malaria among the forest-aboriginal and 
rural communities in Lipis district, Pahang state. 
 
2. To investigate the treatment of malaria with traditional plants remedies, 
including the use, preparation and administration. 
 
3. To investigate the safety, LD50 (acute oral toxicity) of the plants extracts. 
 
4. To study the phytochemical screening of the plants extracts. 
 
5. To evaluate the radical scavenging antioxidant capacity of the tested extracts. 
 
6. To investigate the in vivo anti-malarial activity of different concentrations of the 
plants extract against P. berghei in mice. 
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1.2 HYPOTHESES 
 
1. Community knowledge, attitude and practices (KAP) regarding malaria in the 
endemic areas is inadequate. 
 
2. People in the remote and rural malaria endemic areas are using medicinal plants 
to fight the disease. 
 
3. Malaysian medicinal plants used by the remote and rural communities are safe 
and possess anti-malarial activity.  
 
4. The Malaysian folkloric medicinal application of the anti-malarial plants has a 
pharmacological basis. 
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CHAPTER II 
 
LITERATURE REVIEW 
 
2.1  INTRODUCTION TO MALARIA 
 
Malaria (from the Italian mala aria – bad air), the oldest and cumulatively the deadliest 
of the human infectious diseases, seeped into our very earliest human history. Malaria 
has infected humans since at least 20,000 years ago (Pennisi, 2001).  Hippocrates was 
the first to describe clearly the different types of malaria, some 2,500 years ago, 
depending on the periodicity of the fever—tertian and quartan fever patterns. In 
Hippocratic era, malaria was known as ‗the fever‘, to the Romans as ‗intense burning 
heat‘ (febris ardens) (Cunha & Cunha, 2008).  
 
 In the modern era, it was known to the French and English as ‗fever and chills‘ 
and ‗seasonal fevers‘, respectively. In Osler‘s time, malaria was also acknowledged as 
the fever of summer/fall (Cunha & Cunha, 2008). Significant efforts were made to find 
out the causative agent of malaria, its treatment and preventive measures against it. But 
was not revealed, until the year 1880, when Laveran discovered disease-causing 
protozoa in the blood of patients with malaria in Algeria (Schulze, 2006). Seventeen 
years later, the anopheles mosquito was confirmed to be the vector for the disease by 
Roland Ross (Burfield & Reekie, 2005; Schulze, 2006). Following this the most 
important features of the epidemiology of malaria appeared clear, and control 
procedures in progress to contain this fatal threat.  
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Plasmodia parasites are belong to the coccidian stem of the Coccidiasina sub-
class and reveal most of the representative characteristics of the Apicomplexa phylum 
(Table 2.1). Plasmodia demonstrate asexual development stages in the tissue and blood 
of the vertebrate host (intermediate host) followed by sexual development stages in the 
insect vector (definitive host). 
 
                    Table 2.1: Scientific classification of Plasmodium 
 
  
 
 
 
 
 
 
 
 
Five different species of genus Plasmodium infects humans, Plasmodium 
falciparum (the most effective parasite in causing malaria), Plasmodium vivax, 
Plasmodium ovale, Plasmodium malariae and Plasmodium knowlesi. P. knowlesi, a 
simian malaria parasite of the long-tailed macaque monkeys, was reported in Malaysia 
as a new malaria species infecting human (Singh et al., 2004).  
 
 
 
Sub-kingdom Protozoa 
Phylum Apicomplexa 
Class Sporozoasida 
Sub-class Coccidiasina 
Order Eucoccidiorida 
Sub-order Haemospororina 
Family Plasmodidae 
Genus Plasmodium 
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The life cycle of the Plasmodium genus is shown in Figure 2.1.  The 
Plasmodium species, with the exclusion of P. knowlesi and P.malariae (which may also 
infect the higher primates) are exclusively parasites of man. Only 66 out of the 380 
species of Anopheline mosquitoes can transmit malaria (Burfield & Reekie, 2005). 
 
When a human is bitten by a female anopheline mosquito, infective sporozoites 
are passed into the blood stream, traveling to the liver and hepatocytes. The sporozoites 
undergo asexual reproduction to form exoerythrocytic shizont. The shizont matures and 
bustes releasing merozoites (PNAS, 2010). 
 
Merozoites go through the bloodstream and infect red blood cells. After a few 
cycles of erythrocytic shizongony some merozoites develop into micro and 
macrogametocytes, which no longer have further activity within the human host. When 
vector mosquito feeds on the human blood the gametocytes are taken up and develop in 
its gut, where exflagellation of the microgametocytes take place to form the 
microgamete.  The microgamete fertilized macrogamete resulting is ookinete which 
penetrates the epithelial lining of the midgut, and develops into an oocyst. Sporogony 
within the oocyst generates many sporozoites and where the oocyst ruptures, the 
sporozoites migrate to the salivary gland, and ready for injection into another human 
host (PNAS, 2010).  
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Figure 2.1: The life cycle of the Plasmodium genus 
Source: PNAS (2010) 
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P. knowlesi, the fifth malaria species infecting human, occurs in most countries 
of South East Asia including Malaysia, Thailand, Philippine and Singapore 
(Jongwutiwes et al., 2004; Singh et al., 2004; Luchavez et al., 2008; Ng et al., 2008). In 
Malaysia, it is mostly reported in Sabah, Sarawak and Pahang (Indra et al., 2008). For 
diagnosis of P. knowlesi, molecular methods are necessary for confirmation since it is 
regularly misrelated as P. malariae because their RBCs stages are difficult to 
microscopically differentiated (Cox-Singh et al., 2008). In 1968, Chin et al. reported P. 
knowlesi infection as a zoonosis (animal to human) and reverse zoonosis (animal to 
human) in a laboratory setting. This emergence of zoonotic malaria parasite is of major 
public health significance especially in the rural interior region. 
 
As highlighted in the world malaria map 2010 (Figure 2.2), three regions 
significantly affected by malaria are Africa, Latin America and Asia. Globally, in 2009, 
there were 225 million cases of malaria and almost one million deaths (WHO, 2010). 
More than 80% of this mortality occurs in Africa followed by about 15% in Asia and 
Eastern Europe. Moreover, about 66% of Africa population and 49% of Asia are at risk 
of infection (WHO, 2005).  
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Figure 2.2: Malaria world map 2010 indicating the areas; (green) in which malaria 
transmission occurs, (pale green) area with limited risk, and (white) no 
malaria 
 
Source: WHO (2011) 
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2.2  MALARIA IN MALAYSIA  
 
2.2.1 The Country Profile 
 
Malaysia is a country of Southeast Asia; it has a maritime border with the Philippines 
and Indonesia from the east, west and south, and land borders with Singapore, Indonesia 
and Thailand from the east and south and north. Malaysia has an estimated land area of 
329,758 km
2
. Malaysia Federation consists of 13 states and three federal territories 
(Wilayah Persekutuan), and is divided into two parts: 11 states and two federal 
territories in Peninsular Malaysia and two states and one federal territory in East 
Malaysia (Figure 2.3). South China Sea separates West and East Malaysia by about 640 
kilometers. Kuala Lumpur is the capital city, however, Putrajaya, is being developed as 
the new governmental city.  
 
 As stated by the Department of Statistics Malaysia (2010), the population of 
Malaysia was estimated at 28,250,000. In Malaysia, there are different ethnic groups 
where Malays compose 50.4%, Chinese and Indians about 30.8%. Indigenous groups, 
include Orang Asli (Aborigines) (Peninsular Malaysia), Kadazans (East Malaysia),  
Ibans (East Malaysia) and various other groups, compose 11.0% of the total population 
whereas 7.8% is entitled as others who have chosen to make Malaysia their home. The 
population density is about 85.8/km
2
. The infant mortality rate in 2009 was six deaths 
per 1000 births, and life expectancy at birth in the same year was 75 years (UNICEF, 
2011). The population proportion below 15 years of age was 33.3% in 2005, and the 
males- female proportions are 50.9%-49.1%, respectively (Al-Mekhlafi, 2008).  
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Figure 2.3: The states and federal territories of Malaysia 
Source: Golbez & Mdzafri (2009) 
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2.2.2 Malaria Status in Malaysia 
 
In Malaysia, malaria stills an important public health issue in rural and aboriginal 
people (Orang Asli, in Malay areas). Orang Asli are the indigenous inhabitants of 
Peninsular Malaysia, living in remote forest areas and compose only 0.6% of the total 
population (Al-Mekhlafi et al., 2008). About 2.2 million people are at risk of infection 
with the disease with incidence and mortality rates of 2.01/100,000 and 0.33 %, 
respectively (VBDCP, 2008). It is endemic in Sabah and Sarawak, and some areas of 
West Malaysia (VBDCP, 2008).   
 
 Four malaria species were reported in Malaysia including Plasmodium 
falciparum, P.vivax, P.malariae and P. knowlesi (Singh et al., 2004; Jamaiah et al., 
2005; Ahmad & Mahani, 2008; WHO, 2010). A confirmed imported P. ovale case was 
detected by the Department of Parasitology, University of Malaya in the blood of a 20-
year-old Nigerian male student (Yvonne et al., 2010). Many malaria endemic areas have 
more than one mosquito vector species where each species can be either a primary or 
secondary vector of malaria transmission. Only ten Anopheles species have been 
reported as vectors namely Anopheles maculatus, An. balabacensis, An. Latens, An. 
dirus, An. letifer An. campestris, An. donaldi, An. sundaicus, An. leucosphyrus and An. 
flavirostris (Rahman et al., 1997; VBDCP, 2008; Ahmad & Mahani, 2008). 
 
 Malaria control in Malaysia, dated back to 1901, which was developed to the 
malaria eradication program in 1967 and then to the vector-borne diseases control 
program in 1986, that resulted in a great reduction in malaria prevalence from 181,495 
in 1967 to 7010 in 2009, of which 8% were imported (VBDCP, 2009; WHO, 2010) 
(Figure 2.4).  
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Figure 2.4:  Malaria burden in Malaysia 1961-2008  
Source: VBDCP, Ministry of Health, Putrajaya, 2009. 
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 Malaysia is now aiming to eliminate the disease from the country by introducing 
a malaria elimination program in the 9
th
 Malaysia Plan, in the hope to ensure there are 
no indigenous malaria cases by 2015.  However, the data received from the VBDCP, 
Ministry of Health in the 2008 showed that there was an increase in incidence of 
malaria in some rural and remote areas (Figure 2.5). One of those areas which 
demonstrated an increase in the malaria infection is Lipis district located in the state of 
Pahang (VBDCP, 2009; WHO, 2010).  
 
 The key components of malaria control in Malaysia are indoor residual spraying 
(IRS), insecticide treated bed nets (ITNs) including Long-lasting insecticidal nets 
(LLINs) and early diagnosis and treatment supplements (WHO, 2010). 
 
In 1963, malaria resistance to chloroquine was first reported in West Malaysia 
(Montgomery & Eyles, 1963), followed by several reports from East and West parts of 
the country (Clyde et al., 1973). A widespread spread chloroquine and sulfadoxine-
pyrimethamine resistant P. falciparum were also reported by Lokman et al. (1996) in 
West Malaysia. In 2001, existence of chloroquine and sulphadoxine-pyrimethamine 
combination resistance was confirmed in Terengganu and Perak states (Talisuna et al., 
2004).  
 
Furthermore, the temperature in Malaysia has been anticipated to increase by 
0.18 
O
C per decade (Chong & Mathews, 2001). Hence, tropical diseases such as malaria 
will rise as a result of that increase in the temperature, as mosquitoes prosper on these 
climatic changes. ―Global warming would increase the temperature of areas where 
mosquitoes could not live previously and infect more people with diseases‖, said, Datuk 
Seri Azmi Khalid (2007). 
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Figure 2.5: Trends in malaria cases in Malaysia, 2005–2009 
(WHO, 2010) 
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2.3 CHALLENGES FACING MALARIA CONTROL 
 
Despite substantial efforts to eradicate malaria in the last century, it remains serious 
infectious disease in most developing countries. Furthermore, this deadly disease comes 
back to some countries which had previously eliminated it, and transmitted to further 
regions such as Eastern Europe. 
 
Control of malaria depends on a combination of different means against the 
insect vector and health-control interventions to treat the disease including insecticide-
treated bed nets, indoor spraying, drainage, insect-growth regulators, and biological 
means for larval control, drug treatment and vaccination (Curtis, 1991; Takken & Scott, 
2003). While these means and interventions help to decrease the prevalence of the 
disease by break of transmission, they do not eradicate the parasite (Takken & Scott, 
2003). Moreover, it has been confirmed that it is farther complicated to eradicate an 
insect vector, and anywhere successful control has been arrived, this was often the result 
of short-term interruption of transmission to clear the human host of the parasite as has 
been the case for malarial disease (Takken & Scott, 2003). 
 
There are several aspects which contribute to these challenges including the lack 
of efficient vaccine, the drug resistance which is an increasing problem in Asia, Africa 
and South America, ineffective control of malaria mosquito vector. Furthermore, failure 
to diagnose malaria in the early stage of infection often leads to mortality that could 
have been avoided by timely therapy (Fischer & Bilek, 2002). Poverty and malnutrition 
increases the susceptibility of individual in endemic areas to malaria and increases the 
mortality rate (Sharma, 2009).   
 
 19 
 
 Pesticides such as dichlorodiphenyltrichloroethane (DDT) are still applied in 
indoor residual spraying to control the mosquito vector in many countries. Even though 
it has to some extent useful in reducing the incidence of malaria, it has also caused 
various long-term negative affects and a resistance of mosquito vectors to DDT were 
reported (Talisuna et al., 2004).  
 
Global warming represents a new challenge facing malaria control. Conjectures 
on the prospective effect of climate change on human healthiness commonly meet on 
mosquito-borne diseases. Relevant studies proposed that higher climate temperature will 
increase the transmission rates of mosquito-borne diseases (Reiter, 2001). In the coming 
decades, forecasts indicate a massive increase in malaria cases that would happen in 
endemic areas, and the transmission would reach the higher altitudes (Reiter, 2008).  
 
Population development, urbanization, deforestation, new agricultural and 
irrigation projects and immigration have all created new breeding sites for the disease 
vector, resulted in increasing of malaria transmission and farther epidemics (Hardwicke, 
2002; Wangchuk, 2004). 
 
All these factors represent serious problems facing malaria control programmes 
in many parts of the world and leading too much higher rates of disease and deaths. 
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2.4 MALARIA DRUG RESISTANCE 
 
Malaria drug resistance is a real obstacle facing malaria control efforts. The appearance 
of drug resistance led to increasing the disease mortality rates and drugs cost. Resistance 
of P. falciparum against a variety of drugs is prevalent and showing fast decline in drug 
sensitivity for the period of the past decade. To a slight level, resistance of the others 
Plasmodium species has been reported in some countries such as Indonesia, Myanmar 
and India. Drug resistance is responsible for the extent and recurrence of malaria to new 
regions that had previously eradicated the disease and also taken part in the occurrence 
and seriousness of epidemics (Ridley, 1997).  
 
The main mechanism responsible for the emergence of resistance to anti-
malarial agents is biologically acquired genetic mutations in Plasmodium species with 
the aim to give a survival advantage for the malaria parasite. These mutations are the 
responsible for the decline that exhibited in drug sensitivity (Nagelschmitz et al., 2008). 
Medication of a high biomass infection by giving sub-therapeutic dosage or sub-
standard drug is unable to kill mutant parasites leading to a selective pressure for 
resistance. These mutant parasites with acquired resistance are subsequently transmitted 
to other hosts by vectors. Additionally, it is more likely that drug with long half-time to 
be selected in treating resistant parasites rather than low drug concentrations which only 
be able to cure sensitive species (Falade et al., 2008).  
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2.4.1 Drug Resistant P. falciparum 
 
Southeast Asia has showed a significant responsibility as a center for the growth of drug 
resistance of P. falciparum. P. falciparum resistant to chloroquine first reported almost 
at the same time in Thai-Cambodian border, Thailand and Colombia, Latin America in 
late 1950s (Spencer, 1985; Wernsdorfer & Payne, 1991). In the early sixties, the 
emergency of chloroquine resistance resulted in a considerable rise in death rate 
(Thimasarn, 1999). In the early seventies, chloroquine resistant falciparum strains had 
reached all endemic areas of Southeast Asia, South America and India (Sehgal et al., 
1973; Peters, 1987). At the end of the eighties, P. falciparum resistant to chloroquine 
was prevalent in almost all Asia, sub-Saharan Africa and Oceania (WHO, 1997).  
 
The widespread of the resistance of P. falciparum strains to chloroquine led to 
the use of other anti-malarial drugs like quinine, sulphadoxine-pyrimethamine and 
Mefloquine in the seventies. Resistance to sulphadoxine-pyrimethamine and quinine 
was early observed in 1960s from Thai-Cambodian border (Bjorkman & Phillips-
Howard, 1990; Pickard & Wernsdorfer, 2002). Since then, sulphadoxine-pyrimethamine 
and quinine resistance have been observed in several places of Southeast Asia, Western 
Oceania, South of China, South America and Africa (Aramburu et al., 1999; WHO, 
2001a; Jelinek et al., 2001; Zalis et al., 1998). In the late eighties, the sulphadoxine-
pyrimethamine resistance it was no less than 90% in Brazil (Souza, 1992),  
sulphadoxine-pyrimethamine resistance was detected in India  (Choudhury et al., 1987) 
and mefloquine resistant P. falciparum strains was first reported from the Thai-
Cambodian border (Wongsrichanalai et al., 2001).  
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Cross-resistance among halofantrine and mefloquine is proposed by reduced 
response to halofantrine when used to treat mefloquine failures (Kuile, 1993). Multidrug 
resistant is typically referring to resistance to both chloroquine and sulphadoxine-
pyrimethamine, but may also include resistance to other compounds as well (Bloland, 
2001). 
 
Artemisinin (known as qinghaosu) and its derivatives are the most recent anti-
malarial drugs. They possess the most rapid action of all current drugs against P. 
falciparum. However, evidence of artemisinin-resistant falciparum malaria has been 
reported on the Thai-Cambodian border (Pickard et al., 2003; Dondorp et al., 2009). 
 
2.4.2 Drug Resistant P. vivax and P. malariae 
 
Chloroquine resistance in P. vivax was unidentified until 1989, when Australians sent 
home from Papua New Guinea failed regular treatment (Rieckman et al., 1989). 
Following reports confirmed that finding, where chloroquine resistant P. vivax strains 
were reported from Indonesia, Myanmar and India (Schwartz et al., 1991; Marlar-Than 
et al., 1995; Dua et al., 1996). Surveys in Indonesia
 
exposed a higher risk in the east of 
the country (Baird et al., 1996; Sumawinata et al., 2002). Resistance of P. malariae to 
chloroquine was observed in Indonesia (Ridley & Fletcher, 2008). Drug resistant P. 
ovale as well as P. knowlesi parasites have not yet been documented. 
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2.5 URGENT STRATEGIES TO CONTROL MALARIA 
 
2.5.1 Combination Therapies  
 
The growth of malaria resistance holds back the anti-malarial control tactics. Anti-
malarial drugs combination to control multidrug resistant malaria is an urgent need. The 
benefits of each candidate treatment of drugs combination must suspiciously be taken 
into account for particular malaria endemic areas, where the disadvantages of the 
selection may have an effect on upcoming drug policies and ability to manage mortality 
due to this serious disease (Farooq & Mahajan, 2004). 
 
WHO (2001b) advocates all territories suffering resistance to regular mono-
therapies, for instance chloroquine and sulfadoxine/pyrimethamine, be supposed to 
employ artemisinin-based combination therapies (ACTs) used for P. falciparum.  
 
The idea of using drug combinations to delay malaria drug resistance came from 
Peters (1990). The rational for experiencing this combination is properly launched in 
tuberculosis treatment and cancer chemotherapy (Yeung et al., 2004). The curative rates 
through employing combinations can be sustained and this tactic keeps medicines in a 
mutual fashion (Olliaro & Taylor, 2004). However, the basis to success in this issue is 
to keep using these combinations against the parasites that are still sensitive to the used 
drugs (Bloland, 2001). 
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The chance of Plasmodium species developing resistant at the same time to two 
drugs is:  
Mutation frequencies/parasite × the total No. of parasites subjected to drugs 
(White, 1999; Yeung et al., 2004).  
 
The options for malaria treatment are restricted to the following drugs: 
chloroquine, sulphadoxine/pyrimethamine (SP), amodiaquine, mefloquine, 
dihydroartemisinin, artesunate, the recently registered atovaquone/proguanil, 
chlorproguanil/dapsone (LapDap), dihydroartemisinin-piperaquine, and 
artemether/lumefantrine (Olliaro & Taylor, 2004; WHO, 2006). 
 
2.5.2 New Anti-Malarial Agents from Medicinal Plants 
 
As showed above in the discussion of combination therapies to overcome malaria 
resistance, this strategy represents a delay of malaria resistance to the treatments 
currently available in the markets. Currently no single drug is successful for treating 
multi-drug resistant Plasmodium malaria. In addition resistances to artemisinin-
derivatives (Pickard et al., 2003; Dondorp et al., 2009) and to drug combination 
therapies (Wichmann et al., 2004) have already appeared. Hence, in the lack of an 
effective, safe and commonly available malaria vaccine, attempts to develop new anti-
malarial drugs continue to being urgently needed. 
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Consistent with this specification for the production of new anti-malarial agents, 
traditional medicinal plants have several potential advantages; they are affordable, 
easily accessible and there is no evidence of resistance to whole-plant extracts. 
Moreover, traditional medicinal plants have been used to cure this fatal disease for 
hundreds decades and they represent the ingredients of the two major classes of modern 
anti-malarial drugs; artemisinin and quinine derivatives (Cordell et al., 1994; Willcox & 
Bodeker 2000; Willcox and Bodeker, 2004; Batista et al., 2009).  
 
The first major research on anti-malarial activities from plant extracts was 
started in 1947 by the screening of 600 species of plants belong with 126 families but it 
was only in the mid 1980s that the testing of these plant extracts was completed 
(Phillipson, 1999). The research found several plants, particularly in two families; the 
Simaroubaceae and Amaryllidaceae were active against avian malarias (Phillipson, 
2001).  
 
2.6  FURTHER STRATEGIES TO CONTROL MALARIA 
 
Different strategies to the above are at present being studied in an effort to eradicate or 
at least contain the malaria problem. The most important of these are discussed below. 
 
2.6.1 Small interfering RNAs (siRNA) 
 
David Baulcombe's group interfers the RNA interference (RNAi) pathway by the 
addition of double stranded RNA (dsRNA) to the pertinent cells or organism (Hamilton 
& Baulcombe, 1999).  The double stranded RNA is then cleaved into smaller RNA 
fragments by RNAase III-like enzyme (Dicer) (Schulze, 2006). The mature single-
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stranded siRNA are degraded and translationally inhibited by direct them to bind to 
untranslated regions of target mRNAs (Xue et al., 2008). 
 
 Researches who take advantage of this pathway in the fight malaria are on in full 
swing. However, to date no RNA interference (RNAi) gene candidates have been 
identified in the experimental Plasmodium species, P. berghei (López-Fraga, 2008). 
 
2.6.2 Structure-Based Drug Discovery 
 
Structure-based drug discovery is a further tool to discover potent anti-malarial drugs; it 
is still in its infancy for most targets. This drug development approach involves the 
identification of practicable target proteins and detection of its three dimensional 
structure by X-ray crystallography method. Lactate dehydrogenase, triosphosphate 
isomerase and plasmepsin II Plasmodium enzymes are the most highly developed 
targets of this pathway of anti-malarial drug discovery to offer significant progress in 
better understanding the selective inhibition of these enzymes as well as mutational 
changes leading to drug resistance (Mehlin, 2005).  
 
 Protein expression remains a basic challenge facing this tool of anti-malarial 
drug development, and there is, up to now, no simple solution to this difficulty (Mehlin, 
2005). Moreover, the function of about 60% of the encoded genes of P. falciparum 
genome sequence is not understood (Gardner et al., 2002).  
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2.6.3 Genetically-Modified Mosquitoes 
 
Genetically-Modified Mosquitoes is aimed to design genetically modified mosquitoes, 
which are unable to transmit malaria parasites (Catteruccia et al., 2000; Schulze, 2006; 
Wilke et al., 2009). Recently, this was realized in the mosquito Anopheles stephensi 
Liston, which was transformed in order that binding of the malaria parasite Plasmodium 
berghei to the midgut membrane of A. stephensi and sporozoite passage through the 
epithelium of the salivary glands were considerably reduced (Ito et al., 2002). In view 
of the fact that Ito‘s trail was carried out using rodent malaria, further studies are 
required using a human model (Schulze, 2006). 
 
Perspectives works in this field is the successful application of the RIDL system 
to Drosophila melanogaster (Thomas et al., 2000) which can potentially be adopted to 
be used in mosquitoes and other vectors of human pathogens. The RIDL system has 
recently been adopted for use in Aedes aegypti, based on a non-female-specific 
construct (LA513) (Phuc et al., 2007), which produces mosquitoes that die as larvae 
without tetracycline, but can develop normally when raised in the presence of this drug 
(Wilke et al., 2009). In addition, new genetic constructs have been proposed that rely on 
the use of a promoter specifically began in immature Aedes aegypti females, known as 
Act4 (Muñoz et al., 2004). These systems have shown hopeful results in the laboratory 
and field tests are expected to have begun in Malaysia (Lee et al., 2008).  
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2.6.4 Malaria Vaccine 
 
A vaccine is hard to develop against malaria infection because of the incidence of 
antigenic polymorphism. Genetic polymorphism of the different species as well as 
stages of malaria species is a main reason behind the ability of the parasite to survive 
regardless of the immune responses produced by the human (Martin et al., 1987). 
Furthermore, the slow progress of immunity in the infected hosts residing in malaria 
endemic areas is in agreement with the suggestion that efficient immunity merely 
develops following experience to several of genetically diverse Plasmodium species 
strains (Talisuna et al., 2004).  
 
The existing clinical trials to develop vaccines against malaria utilize a number 
of stage specific antigens. The proteins targeted by the vaccines include sporozoite 
surface antigen-2 (SSP-2), circumsporozoite protein (CSP), merozoite surface antigen 
(MSA-1), apical merozoite antigen (AMA), liver stage antigen-1 (LSA-1), serine rich 
antigen (SERA), a sexual stage antigen of P. falciparum (Pfs25) and schizont export 
antigen 5.1 (Schulze, 2006). Some of these trials unfortunately met with no success.  
 
To date RTS, S/AS02A is one of the most useful vaccine efforts to develop 
important protection against Plasmodium infection. It is containing containing 
circumsporozoite protein (CSP) combined with a hepatitis B surface antigen. It affords 
limited protection against malaria in naive and hyper-immune adult volunteers (Alonso 
et al., 2004; Dubois et al., 2005; Schulze, 2006). The Walter Reed Army Institute of 
Research developed that vaccine to protect their troops sent into endemic areas of 
malaria (Bojang et al., 2001; Kester et al., 2001). The vaccine has a protective activity 
up to six months and found to be effective, safe and tolerated in clinical trials (Alonso et 
al., 2004; Schulze, 2006; Aponte et al., 2007). Many other candidate vaccines are in 
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progress, but the trial results of this one, published in the Lancet, is the most promising 
yet. This strategy is being studied further (Schulze, 2006).  
 
 
2.7 AWARENESS OF COMMUNITY REGARDING MALARIA 
 
Ignoring community‘s knowledge, attitudes and practices (KAP) about malaria has led 
to the lack of ability to attain sustainable malaria control programmes. Knowledge 
community‘s awareness of transmission, symptoms, treatment and prevention of 
malaria is a vital step to control the disease (Govere et al., 2000; Simsek & Kurcer, 
2005). The 1998 Roll Back Malaria (RBM) programme, launched in Geneva by WHO, 
UNDP, UNICEF and the World Bank, is a people oriented plan that emphasises 
community involvement (Udonwa et al., 2010). The participation of the community 
represents one cardinal tool of malaria control programs by WHO as the improvement 
of understanding of transmission of malaria can greatly increase the realization and 
sustainability of malaria elimination program (Hlongwana et al., 2009). 
 
There have been many studies regarding the knowledge, attitudes and practices 
concerning malaria in different parts of the world. Various knowledge, attitudes and 
practices (KAP) surveys show these misconceptions related to malaria exist and 
practices for the control of malaria have been inadequate (Nyamongo, 2002; Swe & 
Pearson, 2004; Oguonua et al., 2005; Xia et al., 2007; Joshi & Banjara, 2008; Udonwa 
et al., 2010). Providing efficient health education has often been showed as a potential 
response so those communities residing in malaria endemic areas are made aware of the 
transmission, the preventive measures and the seriousness of the disease. 
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Knowledge, attitudes and practices surveys to study awareness of a community 
concerning malaria are appropriate to plan and enhance malaria control programmes, 
put epidemiological and behavioural database and ascertain guides for supervising a 
programme‘s success (Macheso et al., 1994). The outcomes of these studies can be 
adopted to fit the local requirements of the community based on the information 
resulted from such survey data (Ongore et al., 1989). For instance, a community‘s 
awareness of malaria transmission, treatment-seeking behaviour and vector control can 
be applied to establish clearer knowledge, attitudes and practices of the population 
enabling the use of efficient tools for health education and improving and sustaining 
good practices for malaria prevention. (Miguel et al., 1999; Mazigo et al., 2010). 
Accordingly, the results of these types of studies will assist the health authorities into 
the decision making processes, the design of interventions with active community 
participation, and the implementation of educational schemes (Paulander et al., 2009). 
Furthermore, community awareness about a particular disease prepares the ground for 
the work of specialized studies on the disease in that community. For example, the study 
of people‘s knowledge on anti-malarial plants requires studying the community‘s 
knowledge of the disease itself. People's awareness of the disease lays the groundwork 
for any study related to the disease. In this study, this methodology has been followed. 
 
Although malaria control program in Malaysia has been going on more than a 
hundred years, but there is no survey on knowledge and practice of the population 
concerning malaria. In parallel with the implementation of Malaysia's malaria 
elimination programme, this study was carried out to investigate the knowledge, attitude 
and practices about malaria transmission, treatment and vector control between the 
hill/forest and the rural communities in Peninsular Malaysia.  
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2.8 ETHNOBOTANICAL PLANTS AS A SOURCE OF ANTI-MALARIALS   
 
The use of plants for medicinal purposes is an ancient idea, as confirmed by the earliest 
documented uses uncovered in Babylon and ancient Egypt (1770 BC and 1550 BC, 
respectively). Ancient Egyptians believed that remedial plants were even efficient in the 
life after death of their Pharoahs, as revealed by the plants recovered from the Giza 
pyramids (Veilleux & King, 1996). In the Third World, 80% of people are estimated to 
rely on plant remedies (WHO, 1993). Moreover, the medicinal plants are responsible for 
the development of many modern synthetic anti-malarial agents (Figure 2.6). 
 
Quinine is an aminoquinoline alkaloid that isolated from Cinchona species bark 
was the first anti-malarial agent of plant sources. It was discovered in 1820 by Caventou 
and Pelletier (Phillipson, 2001). The quinine molecule has been considered responsible 
for the production of synthetic drugs of 4- and 8-aminoquinolines, such as chloroquine 
and primaquine after the Second World War (Coatney, 1963). With the discovery of 
these drugs, malaria was eradicated from the developed countries and parts of the 
developing countries in South America and Asia and the seeking for novel anti-malarial 
drugs became less important for these countries (Wangchuk, 2004). 
 
Chloroquine was used as the treatment of choice against all species of malaria 
parasites for many years as a result of its high curative activity, low toxicity, low cost 
and still used to treat malaria in some areas in the developing countries where drug 
resistance has not yet reported (Krettli et al., 2001).  
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Figure 2.6: Structures of important anti-malarial molecules of current use to treat 
malaria 
Source: adapted from Krettli et al., 2001 and Batista et al., 2009. 
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From Tabebuia species indigenous to South America, naphthoquinones 
coumpounds were produced (Heinrich et al., 2004). They have supplied a molecule 
template on which atovaquone was developed. A combination of Atovaquone and 
proguanil was approved for clinical anti-malarial use (Edstein et al., 2005).  
 
Artemisinin is another example of a novel sesquiterpene endoperoxide anti-
malarial agent that developed in 1972 from a traditional medicinal plant, Artemisia 
annua. It is used for thousands of years to cure malaria in Chinese folkloric medicine 
(Krettli et al., 2001; Saxena et al., 2003). The isolation of artemisinin led to reiterating 
many research groups to search for new anti-malarial agents from plants that have 
enthnopharmaclogical basis and provoked the evaluation of anti-malarial activity of 
natural peroxides (Klayman, 1985; Krettli et al., 2001). 
 
Thus, it becomes clear that plants have proved to be an important basis of 
malaria treatments. Therefore, it is vital that other medicinal plants that have 
ethnobotanical standing are investigated, to ascertain their efficacy, and to reveal their 
ability as supplies of new drugs in coping with the spread of malaria parasites 
resistance.  
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2.8.1 Ethnobotanical Approach to Anti-Malarial Plant Selection 
 
Ethnobotany is the study of the useful association between human and plant including 
medicinal uses (Hershberger, 1896). Usage of medicinal plants by people regularly 
concerns to their importance in the community, medicinally, religiously or traditionally.  
Medical ethnobotany has great importance in drug discovery; it saves effort and 
confirms the suspicion. The plants studied through the medical ethnobotany tend to be 
safe and active and therefore laboratory tests will be mostly positive (Gottlieb et al., 
2002). Moreover, medical ethnobotanical information create a prediction by the 
researchers regarding the biological activity of plant, for example, if the designated 
plant used against malaria, and laboratory tests showed negative results that this plant 
may be has indirect effects, it may be that the plant is very useful in reducing the body 
temperature. Medical ethnobotany is very important in keeping information about the 
plants used to treat malaria and circulation these information between generations 
(Koch, 2005). Many novel drugs have been discovered through the active medical 
heritage of medicinal plants such as quinine. Thus, the search of anti-malarial drugs 
through ethnobotanical survey could lead to the discovery of new therapeutic structures 
of anti-malarial drugs.  
 
 Ethnopharmacology and medical ethnobotany: ethnopharmacology is the study 
showing a relationship among ethnic groups, their health, and how it correlates to their 
physical habits and methodology in making and using medicines (Etkin, 1996). On the 
other hand, medical ethnobotany searches for incorporate ethnobotany and 
ethnopharmacology by exploring the field study factors affecting medicinal plant 
knowledge followed by laboratory analysis of the toxicity and activity of the plants used 
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by the people to increase the plant‘s therapeutic understanding values for people who 
depend on them and for possibly discovering new drugs (Lewis, 2003; Koch, 2005). 
 
Currently, efforts to document the data about anti-malarial plants used in 
traditional plant medicine become important for the additional anti-malarial laboratory 
investigations and for isolating and identifying of new anti-malarial drugs (Cox, 1994), 
which is reflected by intensive ethnobotanical studies (Phillipson 2001; Zhang et al., 
2002; Weniger et al., 2004; Asase et al., 2005; Zirihi et al., 2005; Botsaris, 2007; 
Nguyen-Pouplin et al., 2007; Namsa et al., 2010).  
 
2.8.2 Anti-Malarial Activity of Traditional Medicinal Plants Crude Extracts 
 
The discovery of artemisinin from Artemisia annua and its successful in the treatment 
of malaria have evoked the interest in investigating medicinal plants as sources for new 
anti-malarial agents (Taylor & Berridge, 2006). Currently, efforts to study the anti-
malarial activity of plants have increased dramatically. This subheading presents some 
anti-malarial studies of crude extracts from medicinal plants that showed significant 
activity during the last years.  
 
 In Malaysia, Sahidan et al. (1994), Nik-Najib et al. (1999), Kit-Lam et al. 
(2004), Noor Rain et al. (2007) and Wan Omar et al. (2007) studied the anti-malarial 
activity of some Malaysian traditional plants crude extracts. Eurycoma longifolia, Piper 
sarmentosum, Andrographis paniculata, Tinospora crispa, Jasminium sambac, 
Xylocarpus granatum, Goniothalamus scortechinii and Goniothalamus macrophyllus 
showed considerable anti-malarial effects. 
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In Japan, Hydrangea macrophylla leaf water extract showed a potent in vivo 
anti-malarial activity against Plasmodium yoelii in mice. The treated ICR mice 
exhibited a reduction in P. yoelii parasitaemia to undetectable level following a transient 
recrudescence assay (Ishih et al., 2001). 
 
In Myanmar, Zingiber cassumunar rhizomes, Ferula foetida latex, Myristica 
fragrans whole fruits and Piper nigrum seeds (Hlaing et al., 2008) displayed good 
effects against P. falciparum in vitro. 
 
In India, in vivo anti-malarial dose of one g/kg of Aegle marmelos, Artemisia 
scoparia, Cinnamomum tamala, Enicostema hyssopifolium, Jurinea macrocephala, 
Momordica dioica, Nyctanthes arbor-tristis, and Prunus persica were found to possess 
potent schizontocidal activity (50% and above) against Plasmodium berghei in mice 
(Misra et al., 1991). The following five species used to treat fever or malaria in India 
seems to be of special significance for further anti-malarial studies: Casearia elliptica, 
Holarrhena pubescens, Pongamia pinnata, Plumbago zeylanica and Soymida febrifuga 
(Simonsen et al., 2001). In 2011, Samy and Kadarkari studied the in vivo anti-malarial 
activity of 81 plants crude extracts against P. berghei NK65 in mice, 55.5% of the 
plants extracts gave significant parasitaemia chemosuppression activity.  
 
In Brazil, in vivo anti-plasmodial activity of traditional plants species was 
evaluated experimentally in mice. The crude extracts were investigated in mice at up to 
one g/kg for four days against P. berghei.  Esenbeckia febrifuga, Acanthospermum 
australe, Tachia guianensis and Lisianthus speciosus were partially active against the 
rodent malaria (Carvalho et al., 1991). Potomorphe umbellate, traditional anti-malarial 
plant in Brazil showed strong anti-malarial activity against P. berghei subjected to the 
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4-day suppressive test at 250 and 1250 mg/kg in mice (Amorim et al., 1988). The 
essential oil obtained from leaves of Viola surinamensis caused 100% inhibition against 
development of the young trophozoites to schizonts stage (Lopes et al., 1999).  
 
Anti-malarial effect of 14 traditional medicinal plant species used as anti-
malarial and fever remedies in Central America were investigated against chloroquine 
sensitive and resistant strains of P. falciparum in vitro. Xylopia cf. frutescens, S. 
tonduziana, S. pauciflora, Siparuna andina and Piper hispidum showed significant anti-
plasmodial results (Jenett-Siems et al., 1999).  
 
Panama, Nicaragua,  Guatemala, Costa Rica, Colombia, Bolivia  and Argentina 
medicinal plants; Abuta grandifolia leaves, Acacia farnesiana leaves, Acnistus 
arborescens aerial part, Piper holtonii aerial part, Acnistus arborescens leaves, Piper 
cumanense fruits,  Monochaetum myrtoideum leaves, Croton leptostachyus aerial part, 
Bourreria huanita branch and Xylopia aromatica bark (Garavito et al., 2006; Calderón 
et al., 2010) displayed significant anti-plasmodial activity. 
 
 In Congo, curde extracts of Phyllanthus niruri, Morinda morindoides and 
Cassia occidentalis were investigated against P. berghei ANKA in mice to evaluate 
their in vivo anti-malarial activity. M. morindoides, P. niruri and C. occidentalis 
produced parasitaemia reductions of 74%, 72% and 60%, respectively (Tona et al., 
2001). Albertisia villosa is a traditional medicinal plant used in Congo against various 
diseases. Basic alkaloidal extracts of this plant revealed potent anti-plasmodial activity 
(Lohombo -Ekomba et al., 2004). 
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Of six studies carried out in Nigeria to evaluate the anti-malarial activity of 
some traditional plants used to treat malaria, it was observed that crude extracts of 
Myrtus communis (essential oil), Rosmaricus officinalis (essential oil), Cassia 
singueana (root bark), Artemisia maciverae, Xylopia aethiopica (fruits), Acacia nilotica 
(Leaves), Croton zambesicus (leaves), Cylicodiscus gabunensis (stembark) and 
Euphorbia hirta (leaves) have significant anti-malarial activity (Milhan et al., 1997; 
Adzu et al., 2003; Okokon et al., 2005;  Okokon et al., 2006; Ene et al., 2008; 
Oparaocha & Okorie, 2009).  
 
Five Cameroonian plants crude extracts (essential oils); Antidesma laciniatum, 
Hexalobus crispiflorus, Pachypodanthium confine, Xylopia aethiopica and Xylopia 
phloiodora were screened against P. falciparum. The essential oils of all five plants 
showed active anti-malarial effects against P. falciparum. The highest in vitro anti-
plasmodial activity was shown by the essential oil of H. crispiflorus (Boyom et al., 
2003). In 2005, Tchoumbougnang et al. studied in mice the in vivo anti-malarial activity 
of Cymbopogon citratus and Ocimum gratissimum essential oils used in Cameroon to 
treat malaria. C. citratus and O. gratissimum oils showed significant anti-malarial 
effects against P. berghei in the four-day suppressive assays in mice. C. citratus 
exhibited higher in vivo anti-malarial results than O. gratissimum at the same 
concentration with 86.6 % and 77.8 % suppressions of parasitaemia, respectively.  
 
Kenyan plants utilized in malaria traditional treatment were investigated in vivo 
against P. berghei to evaluate their anti-malarial efficacy. Vernonia lasiopus (root 
bark), Rhamnus staddo (root bark), Clerodendrum myricoides (root bark), Toddalia 
asiatica (root bark), Ficus sur (leaves/stem bark/root bark), Rhamnus prinoides 
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(leaves/rootbark) and Maytenus acuminata (leaves/root bark) have significant 
parasitaemia suppressions against P. berghei NK65 in ICR mice (Muregi et al., 2007). 
 
In vivo anti-plasmodial activity against rodent malaria in mice exhibited that 
Caesalpinia bonducella leaves and Tragia fuliaris roots, used traditionally for treatment 
of malaria in Tanzania have significant anti-malarial action against P. berghei (Innocent 
et al., 2009).  
 
Hybanthus enneaspermus, Croton lobatus, Nauclea latifolia, Fagara 
macrophylla, Funtumia elastica, Phyllanthus muellerianus and Rauvolfia vomitoria, 
used to treat Malaria and fever in Benin and Ivory Coast showed significant in vitro 
activity against cultured P. falciparum (Weniger et al., 2004; Zirihi et al., 2005).  
 
In the Middle East, Nigella sativa, Acalypha fruticosa, Azadirachta indica, 
Dendrosicyos socotrana, Boerhavia elegans, Solanum surattense and  Prosopis juliflora  
used in the folk medicine of Yemen and Iran, showed significant anti-plasmodial 
activity (Abdulelah & Zainal-Abidin, 2007; Alshawsh et al., 2007; Ramazani et al., 
2010). 
 
Without a doubt, with all these worldwide efforts to find plants effective against 
this fatal disease, the goal could be achieved soon. The recently developed 
pharmacological techniques of evaluation, isolation and characterization of natural 
products have caused greater attraction in plants. Thus, the search for new additional 
anti-malarial drugs source from the traditional medicinal plants must keep on combating 
the disease. 
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2.9 SCREENING OF ANTI-MALARIAL PLANT EXTRACTS 
  
 As described in 2.8.2, two methods can be used to assesses the anti-plasmodial 
activity of plant extracts; in vivo using laboratory model P. berghei (rodents malaria 
parasite) or in vitro using cultured P. falciparum (human malaria parasite). However, 
the homeostatic mechanisms and pathways found in animals are not present in vitro. 
The active anti-malarial principles of the extract could be formed by hepatic metabolism 
or as a result of gut bacteria transformation (Botsaris, 2007). Additional promising 
mechanisms of action include immunomodulation, antioxidant activity or interference 
with the invasion of new red blood cells by parasites (Daubener, 1999; Anthony et al., 
2005; Botsaris, 2007). Hence, in this study the in vivo anti-malarial assays were carried 
out. 
 
2.9.1 Anti-Malarial Tests in Mice 
 
There are numbers of animal species that can be used in the laboratory to evaluate the 
anti-malarial activity of chemical compounds and natural products including mouse, rat, 
hamster, monkey and chicken (Table 2.2). Mice are simple to reproduce, obtain, 
maintain, control and involving little amount of plant extracts to be tested, compared to 
other animals (Krettli et al., 2009).  
 
 Evaluation of in vivo anti-malarial activity of plants extract in mice represents 
the largest part of the in vivo anti-malarial tests and considered as standard procedure in 
this field (Peters 1965; Misra et al., 1991; Carvalho, 1991; Peters & Robinson 1992; 
Tona et al., 2001; Fidock et al., 2004; Tchoumbougnang et al., 2005; Muregi et al., 
2007; Krettli et al., 2009). 
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Table 2.2: Animal models and Plasmodium species used in anti-malarial tests 
Animal models Plasmodium species /strains or clones 
Mouse, Rat, Hamster. P. berghei/ NK65, NY, P, KFY, ANKA, 
K173, RC  
Mouse P. yoelii (nigeriense) / MDR, 17X,  ART, 
N67 
Mouse P. vinckei (petteri) / 279BY 
Mouse P. chabaudi /AS 
Mouse P. cynomolgi / Ro, M,  B,  
Rhesus monkey P. knowlesi / W1 
Rhesus monkey P. fragile / Ceylon 
Aotus and Saimiri monkeys, Mouse P. falciparum / Uganda Palo Alto, T24, 
Vietnam Oak Knoll  
Aotus and Saimiri monkeys P. vivax / AMRU1, Palo Alto  
Rhesus monkey P. coatneyi 
Chicken P. gallinaceum/ IOC, 8A 
 
Source: Krettli et al. (2009). 
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When using anti-malarial tests in mice, some changeable need to be taken into 
account throughout the investigation. The course of infection and lethality vary along 
with the mouse strain and the rodent malaria species and subspecies (Sanni et al., 2002; 
Fidock et al., 2004).  
 
The ICR mouse used in this study has been described by Hausckka and Mirand 
(1973). Many studies published in peer reviewed ISI journals have used this mouse 
strain to investigate the anti-malarial activity of plants extracts and new anti-malarial 
agents (Presber et al., 1991; Coleman et al., 1992; Fowler et al., 1994; Ishih et al., 
2001; Ishih et al., 2004; Muregi et al., 2007; Ill-Min et al., 2008; Won-Hwan et al., 
2008; Jong-Jin et al., 2009; Ill-Min et al., 2009). One of the most interested advantages 
of this mouse strain is its easy reproduction compared to other mice. 
 
2.9.2 Rodent Malaria Model: Plasmodium berghei 
 
Rodent malaria infects murine rodents from Central Africa (Figure 2.7). There is no 
evidence to the probability of human infection of these parasites and for this reason; 
they are recognized as valuable parasites for the study in the laboratory. They are 
comparable to human malaria in their life cycle including mosquito infections and 
match most of fundamental characteristics of structural morphology and physiology 
(Carter & Diggs 1977; Landau & Chabaud 1994; Krettli et al., 2009).  
 
 They have been authenticated in the course of the discovery of several anti-
malarial drugs including artemisinin derivatives, halofantrine, mefloquine and drug 
combinations, sulphonamides-pyrimethamine (Peters et al., 1977; Peters, 1987; Peters 
et al., 1987; Vennerstrom, 2000; Posner et al., 2003; Fidock et al., 2004). Rodent 
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malaria Plasmodium parasites also used in anti-malarial drug resistance assays, 
frequently via drug pressure with subcurative doses of drug (Peters, 1965; Walliker et 
al., 1975; Peters & Robinson, 1999). 
 
 P. berghei, P. chabaudi and P. yoelii are the most important species of rodent 
malaria models that still a valuable tool of the anti-malarials studies including liver 
stage biology, vaccine development, mechanisms of drug resistance, antigenic variation, 
plant extracts anti-malarial assays and drug screening (Table 2.3). 
 
 Some advantages to the use of P. berghei in mice for in vivo anti-malarial tests 
in addition to being safe (safe handling), it is extremely virulent to mice reducing the 
time of experiments to about one month time, where control group of mice (non-treated) 
die of rodent malaria infection in one to four weeks of infections (according to the 
mouse and parasite strains) (Krettli et al., 2009). 
 
 P. berghei is extensively used in evaluating the anti-malarial activity of plants 
extracts (2.8.2) and drug screening tests (Table 2.2). Genetically, P. berghei and P. 
falciparum complete genome sequencing demonstrate a high similarity in structure and 
gene content. In addition, genetic engineering technologies can manipulate P. berghei in 
the laboratory (Amino et al., 2005; Janse et al., 2006).  
 
It is always necessary to take into account of certain variables during the 
experimental design and interpretation as rodent malaria parasite species and strains/ 
clones can vary in the course of infection, lethality and synchronicity depending on the 
mouse strain, sex and age (Sanni et al., 2002; Fidock et al., 2004). 
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Figure 2.7: Rodent malaria species - countries of origin 
Source: From Carlton et al. (2001). 
 
 
Table 2.3:  Primary uses of rodent malaria models 
Plasmodium species Primary uses 
P. berghei Plant extracts anti-malarial assays and drug screening 
P. yoelii Liver stage biology and vaccine studies 
P. chabaudi Mechanisms of drug resistance and antigenic variation 
 
Source: adapted from Kalra et al. (2006). 
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2.9.3 In Vivo Anti-Malarial Screening Assays 
      
Plant products reducing parasitaemia by 30% or more during early malaria infection are 
considered active (Krettli et al., 2009) and a series of experiments are carried out to 
confirm their in vivo anti-malarial activities, i.e., 4-Day suppressive test, curative and 
prophylactic methods according to Peters (1965), Ryley & Peters (1970), Peters & 
Robinson (1992), Peters & Robinson (1999), Abosi & Raseroka (2003), Elufioye & 
Agbedahunsi (2004), Bapna et al. (2007), Okokon & Nwafor (2009), Ill-Min et al. 
(2009), Bassey et al. (2009), Madara et al. (2010) and Sathe et al. (2010).  
 
 In these laboratory assays, the test extracts are first evaluated in the 4-day 
suppressive tests in early malaria infection and further screened for their curative 
activity in established malaria infection and prophylactic activity in residual malaria 
infection according to Peters & Robinson (1992), Ryley & Peters (1970) and Peters 
(1965) Protocols, respectively. Most in vivo anti-malarial assays in mice can be 
performed using five animals per group (Fidock et al., 2004). The flow chart of the in 
vivo anti-malarial assays used to evaluate the activity of plant extracts shown in Figure 
2.8 were applied in this study.  
 
 Fundamentally, mice are infected intraperitoneally using a small needle 
inoculum (10
6–107 P. berghei parasitized erythrocytes) (Ishih et al., 2004). To assess 
the anti-malarial activity of the test extract, thin blood films are prepared from the tail 
blood of the infected mice. The blood films are then stained with Giemsa‘s to determine 
P. berghei parasitized erythrocytes (Peters, 1965; Ryley & Peters, 1970; Peters & 
Robinson, 1992).  
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Prophylactic activity test 
 4-day suppression test  
Curative activity test 
Extracts are tested at four 
doses 4x50 mg/kg 
 The percentage of parasitaemia was detected in random fields of the microscope 
by counting P. berghei parasitized erythrocytes out of 9,000 RBCs: 
% Parasitaemia = [No. of parasitized RBC/Total no. of RBC counted] 100 
 Average percentage chemosuppression was calculated as 
    
   
 
  
Where, A is the mean percentage parasitaemia in the control group (untreated group) 
and B is the mean percentage parasitaemia in the test group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.9.4 Phytochemical Screening 
 
Figure 2.8: Flow chart of in vivo anti-malarial activity tests in rodent malaria models 
 
 Adapted from : Fidock et al. 2004; Elufioye & Agbedahunsi, 2004; Kalra et al. 2006; 
Krettli et al. 2009 
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2.9.4 Phytochemical screening 
 
In this study, phytochemical screening was conducted on plants extract according to the 
standard procedures described by Hymete (1986), Trease & Evans (1989) and Sofowora 
(1993). This qualitative screening is of great importance in the prediction about the 
chemicals that may have caused effective suppression against malaria.  
 
 Of those chemicals are alkaloids, anthraquinones, terpenoids and flavonoids 
which are known as active constituents against parasites, protozoa and malaria (Jones & 
Luchsinger 1986; Vishwakarma, 1990; Philipson & Wright 1991; Carvalho et al., 1992; 
Francois et al., 1996; Omulokoli et al., 1997; Kim et al., 2004; Tasdemir et al., 2006). 
Other chemical constituents that recently showed significant anti-malarial effects 
include saponin, tannin, steroids and glycosides (Nandi et al., 2004; Reddy et al., 2007; 
Libman et al., 2008).  
 
 The phytochemical screening results paint a road map for future advanced tests 
of isolation and characterisation of active constituent if the preliminary results showed a 
promising activity against malaria.  
 
2.9.5 Antioxidant Capacity 
 
The immune system in human is stimulated by infections, including parasites, which 
results in the production of reactive oxygen species. On the other hand, nitric oxide 
(NO) is an effective mechanism to kill parasites, which is produced in macrophages in 
response to parasitic infection, which in turn activates the immune response against 
malaria (Daubener, 1999). The inhibition of nitric oxide leads to prepare good 
 48 
 
surroundings for the development of intracellular parasite. On the other hand, these 
inhibition cause a decrease in an essential amino acid, tryptophan, which undergo to 
degradation through indolamine deoxygenase. Hence, the parasite is starved leading to 
its death (Daubener, 1999; Anthony et al., 2005). As a result, immune stimulation and 
release of reactive oxygen species, the haemoglobin in red blood cells exposed to 
degradation (Das & Nanada, 1999; Loria et al., 1999). Therefore, one of the major 
causes for the incidence of anaemia in malaria infection comes into view to be oxidative 
stress (Das & Nanada, 1999; Kremsner et al., 2000; Kulkarni et al., 2003).  
 
 Moreover, some recent studies have shown that the low level of antioxidants in 
the plasma of children with malaria may be a major cause of morbidity and mortality 
(Nmorsi et al., 2007). Accordingly, this confirms that plants that have antioxidant 
activities be able to work against the oxidative damages resulting from malaria; 
therefore, the antioxidant defence system in the Plasmodium parasites may become a 
very hopeful drug target in the near future (Botha, 2006). 
 
 DPPH radical scavenging activity, depended on the capability of an antioxidant 
to provide hydrogen radical to synthetic long-lived nitrogen radical compound DPPH, is 
one of the oldest and most commonly applied procedures to investigate the total 
antioxidant capacity of food and biological extracts (Brand-Williams et al., 1995; Meng 
et al., 2009). Recently, it was observed that there is a good correlation between potential 
DPPH radical scavenging activity and anti-malarial activity of Argan fruit extracts (El 
Babili et al., 2010). 
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2.10 MALAYSIAN ANTI-MALARIAL TRADITIONAL MEDICINAL 
 PLANTS 
  
In countries like Malaysia there is a popular interest in the search for therapeutic 
alternatives to combat the disease, both of alternative medicine based on medicinal 
plants, or by searching for some means known in the folklore of Malaysia. Government 
policies in this country supports the popular interest in alternative medicine based on 
medicinal plants as one of the most important resources of the country, as well as 
recommend widening the circle of knowledge to include the new juveniles to ensure the 
conservation and preservation of folk heritage information (Lin, 2006). Moreover, 
recent studies demonstrated the importance of cooperation with indigenous people and 
traditional healers in the search for the discovery of new drugs from medicinal plants 
(Asase et al., 2005). Therefore, the assessment of the activity and safety of traditional 
remedies is a priority in the search for new drug for malaria, as the safe traditional 
remedies may be considered as an important source in the fight against the disease 
(Asase et al., 2005).  
 
Ministry of Health of Malaysia registered around 1300 medicinal plant products, 
which are available at markets (Lin, 2006). Although many communities have achieved 
successful specific anti-malarial ethnobotanical approaches, in Malaysia few records are 
accessible about the traditional medicinal plants which are still employed to treat 
malaria by the communities residing the malaria endemic areas.  
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Several plants species including Alstonia angustiloba, Brucea javanica, Cassia 
siamea, Phyllanthus niruri, Eurycoma longofolia, Erechtites valerianaefolia, Eurycoma 
apiculata, Panicum palmifolium, Languas galanga, Tinospora crispa, Carbera odollam, 
Elaphantopus scaber are traditionally used in East Malaysia in the treatment of malaria 
and fever (Kamarudin, 1997; Kulip, 1997; Fasihuddin, 2000; Fasihuddin & Holdsworth, 
2003). 
 
Very little is known about the traditional medicinal plants which are still 
employed to treat malaria in Peninsular Malaysia. Hence, the present study was carried 
out to establish a preliminary ethnobotanical database for the plants traditionally used to 
treat malaria among aboriginal and rural communities, and traditional healers in malaria 
endemic areas in Pahang, Peninsular Malaysia. In vivo anti-malarial activity of four 
plant species, namely, Cocos nucifera L. Labisia pumila (Bl.) F.-Vill., Languas galanga 
Stuntz. and Piper betle L. selected based on the ethnobotanical survey and literature 
were evaluated against laboratory malaria model Plasmodium berghei to evaluate their 
anti-malarial activity. 
 
2.10.1 Cocos nucifera L. 
 
The tree of life, Cocos nucifera L. (coconut) of family Arecaceae (palm) is grown in 
villages and towns in Malaysia. Coconut is native to the littoral zone of Southeast Asia 
(Malaysia, Indonesia, Philippines) and Melanesia (Chan & Elevitch, 2006). It is 
pinnate-leaved (4–6 meter long/leaf) plant and can reach 20-30 meter tall; aged leaves 
escape plainly, parting the trunk silky (Pradeepkumar et al., 2008). C. nucifera fruit is 
the used part of this plant providing food for millions of people (Figure 2.9). 
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 Ethnobotanically, coconut white flesh is a folk remedy for fever, flu, gingivitis, 
scabies, rash, venereal diseases, abscesses, bronchitis, sore throat, jaundice, 
dysmenorrhea, earache, erysipelas, skin care, stress relief, digestion, hair care, stomach 
and gastrointestinal problems, typhoid, healing of cuts, injuries, burns and swellings 
(Duke & Wain, 1981; Agero & Verallo-Rowell, 2004; Cano & Volpato, 2004; Peterson, 
2009; Alanis et al., 2005; Lans, 2006; Lans, 2007) .Coconut flesh oil can also prevent 
cancer and heart diseases, regulate blood sugar and strengthen the immune system 
(Hartwell, 1984; Fife & Kabara, 2004).  
 
 The husk fibre of the coconut fruit showed several activities against helminthes 
(Oliveira et al., 2009a), leishmania (Mendonça-Filho et al., 2004) and microbes 
(Esquenazi et al., 2002). However, studies on the phytochemical screening, acute oral 
toxicity of the white flesh and its activity against malaria are non-existent in the 
literature. Hence, this study aims to investigate and find out the phytochemical 
constituents, acute oral toxicity and anti-plasmodial activity of the methanol white flesh 
extract of C. nucifera.  
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Figure 2.9: Cocos nucifera L. fruit. Pos Betau, Kuala Lipis, Pahang, Malaysia. Layers 
of the coconut fruit: (1) Epicarp (2) Mesocarp (3) Endocarp (4) Endosperm, white flesh 
or meat (5) Embryo. 
 
The figure showing the layers of the coconut fruit is from Swathivijay (2008) 
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2.10.2 Labisia pumila (Bl.) F.-Vill. 
 
Labisia pumila or known locally as Kacip Fatimah is one of the most popular medicinal 
plants in Malaysia. Through ethnobotanical market survey, pharmacology and clinical 
trials research, one of the local herbs that have a commercial potential is Kacip Fatimah 
(Zainal Azman, 2007). L. pumila from the family of Myrsinaceae, is a small herb with a 
leaf of about 5-35cm long and 2-8cm wide (Figure 2.10). It is mainly found in the low 
land and hill forests Peninsular Malaysia at an altitude between 300 and 700 m 
(Zaizuhana et al., 2006). 
 
 Ethnobotanically, it is included in many traditional medicinal practices, in 
particular, among Malay women. It is used to induce and expedite labour; assist 
contraction of the birth channel and regain body strength and act as postpartum 
medication to relief pain as well as it is employed to delay fertility (Zaizuhana et al., 
2006; Mojiol et al., 2010). Some other traditional uses include treatment of bones 
diseases, flatulence, dysentery, dysmenorrhoea, gonorrhea and haemorrhoids (Jamia et 
al., 2003).  
 
 Labisia pumila showed many pharmacological effects including larvicidal 
activity against Aedes aegypti mosquito (Ibrahim et al., 2003), anti-bacterial 
(Fasihuddin et al., 1995), topical anti-inflammatory (Nik et al., 2002), anti-
inflammatory, anti-nociceptive and anti-pyretic (Ikujuni et al., 2010). L. pumila also 
showed anti-oedema properties (Rasadah et al., 2001), oestrogenicity activity (Jamia et 
al., 2003), platelet-activating factor receptor binding inhibition (Ibrahim et al., 1996). 
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Figure 2.10: Labisia pumila (Bl.) F.-Vill plant, Rimba Ilmu Botanic Garden of the 
University of Malaya. 
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2.10.3 Languas galanga Stuntz. 
 
Languas galanga Syn. Alpinia galanga (Linn.) Stuntz. (Zingiberaceae) is native to 
grassland areas of Southeast Asia and Southern China (Chevallier, 1996).  L. galanga is 
a robust herb and grows up to a height of 3.5 m tall. The rhizome is fragrant, copiously 
branched in light red or pale yellow (Figure 2.11). It is differentiated from other plants 
known as galangal with the common name greater galangal. In Malaysia, the rhizomes 
(Langkuas) of this plant are used as a spice for flavouring food.  
 
 Ethnobotanically, the rhizomes are used to treat a variety of sicknesses including 
coughs, headache, fever, asthma, bronchitis, inflammation, rheumatoid arthritis and 
colic (Burkill, 1966; Latha et al., 2009). 
 
 Previous biochemical studies on L. galanga have shown that the rhizomes 
contain essential anti-microbial components (Scheffer et al., 1981; de Pooter et al., 
1985; Mori et al., 1995; Charles et al., 1999; Ibrahim et al., 2004). The rhizomes exhibit 
many pharmacological properties, including anti-tumour (Itokawa et al., 1987), anti-
allergic (Matsuda et al., 2003), anti-ulcer (Mitsui et al., 1976), anti-fungal (Janssen & 
Scheffer, 1985), anti-bacterial (Oonmetta-aree et al., 2006) and anti-viral activities (Ye 
& Li, 2006). L. galanga rhizomes also exhibited anti-parasitic effects including anti-
trypanosomal (Nahoko, 2009), anti-leishmanial (Amandeep et al., 2010) and anti-
helminthic (Raj, 1975). 
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Figure 2.11: Languas galanga Stuntz plant, Rimba Ilmu Botanic Garden of the 
University of Malaya. Apparent in the lower right is the Rhizome 
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2.10.4 Piper betle L. 
 
Piper betle L. is a liana belonging to the Piperaceae family (Figure 2.12). It grows in 
most of South and Southeast Asia and prized both as a mild stimulant and medicinal 
plant remedy for a variety of sicknesses (Trakranrungsie et al., 2006; Nalina & Rahim, 
2007; Singh et al., 2009).  
 
Ethnobotanically, the leaves are used to control caries, periodontal diseases bad 
breath (Nalina & Rahim, 2007). It is also used for other purposes including improving 
appetite, tonic for brain, anti-septic for wounds and treatment for diarrhea (Pin et al., 
2010). The leaves are chewed alone or with other plant materials. In ayurvedic 
medicine, it is used to treat bronchitis, cough, asthma, pneumonia, skin diseases, fever, 
impotency, arthritis, anorexia, colic, flatulence, diarrhea and tonsillitis (Ayurvedic 
medicinal plants, 2010). 
 
Recently, the leaves extract exhibited many significant activities against bacteria 
(Nalina & Rahim, 2007), leishmania parasite (Avijit et al., 2008), filarial parasite (Singh 
et al., 2009) and fungi (Trakranrungsie et al., 2006) properties.  
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Figure 2.12: Piper betle L. liana, Institut Pertanian Kuala Lipis, Pahang, Malaysia 
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CHAPTER III 
 
MATERIAL AND METHODS 
 
3.1 STRATEGY OF THE STUDY 
 
A systematic approach was used in this study in order to identify and select the plants 
used to treat malaria in two malaria endemic communities, forest-aboriginal and rural 
communities, in the Lipis district of Pahang state, Malaysia. The study began with 
investigation of people's knowledge, attitude and practices (KAP) regarding malaria and 
collection of ethnobotanical information on plants used by these communities to treat 
malaria. Four plants were selected to evaluate their anti-malarial activity based on the 
ethnobotanical information and literature reports on plant extracts. Only those plants 
that have not been pharmacologically investigated against malaria were chosen in this 
study and they are Cocos nucifera, Labisia pumila, Languas galanga and Piper betle. 
The flow chart of this study is shown in the Figure 3.1. 
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Figure 3.1: The flows charts of the study 
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3.2 COMMUNITY’S AWARENESS REGARDING MALARIA AND 
 ETHNOBOTANICAL SURVEY   
 
3.2.1 Study Area and Population 
 
Lipis district represents the highest prevalence of malaria cases in Pahang state, 
Peninsular Malaysia. It is located 200 km north-east of Kuala Lumpur, Peninsular 
Malaysia with an area of 5,198 km
2
. The climate is tropical with 23-32°C (an average 
temperature) and 1525- 3050 mm (an annual rainfall). Two rural areas inhabited by the 
rural population (Padang Tengku and Benta) and one forest area inhabited by the 
aboriginal peoples (Pos Betau) were involved in this study (Figure 3.2). The three areas 
are situated at a distance of about 25-50 kilometers from one another. About 59 small 
villages (8-40 houses in each village) existed in these areas with approximately 1,000-
1,200 households. In terms of the structure of the houses, 90% of the aboriginal houses 
are made of bamboo and wood and have no toilets and water supply while all the houses 
of the two rural areas are made of cement blocks with toilets and water supply. The 
economy is mostly agricultural with palm and rubber plantations occupying the majority 
of the total land area. Malaria is endemic in the area and varies from one area to 
another, the highest rate of infection being in the aboriginal area (Pos Betau) followed 
by Padang Tengku. The foundations of malaria control performed by the Vector- Borne 
Diseases Control Unit in Kuala Lipis, the capital of Lipis district are impregnated bed 
nets, IRS, early diagnosis and treatment. 
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Figure 3.2: The study area of the field survey; Pos Betau, Padang Tengku and Benta, 
Lipis district, Pahang state, Malaysia. 
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3.2.2 Study Design and Data Collection 
 
Between October and May (2009 -2010), this cross-sectional KAP and ethnobotanical 
survey was carried out among 223 adult households; aboriginal households (house-to-
house interviews, n= 100) and rural households (interviews at outpatient clinics, n= 
123) who had or had not suffered a malaria crisis. Traditional healers (n= 10) were 
added to the studied sample to investigate them knowledge about anti-malarial plants. 
The selection of the participants was according to the availability and willingness of the 
people. Objectives of the study and the role of community were explained during the 
meeting of heads of villages and some households. Participant‘s verbal consent was 
obtained. Knowledge, attitude and practices (KAP) regarding malaria and information 
on plant preparation, application and the parts used to treat malaria were obtained. A 
pre-tested semi-structured questionnaire involved open-ended questions and constructed 
in English and translated into the local language (Bahasa Malayu) was used. All 
participants were interviewed by local trained medical officers to fill up the 
questionnaire.  
 
Semi-structured questionnaire applied in this study was flexible, allowing the 
extraction of as much as possible the answers to the disease during the interview. 
However, semi-structured questionnaire generally has a specific framework of the 
topics that are designed to be explored. Semi-structured questionnaire used in this study 
was according to the standard qualitative communication research methods (Lindlof & 
Taylor, 2002). 
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 Vouchers of the plants were collected and identified by a plant taxonomist from 
Rimba Ilmu and deposited at the Herbarium of the University of Malaya, Kuala 
Lumpur, Malaysia. The floras used for identification were Malayan wild flowers and 
Garden Plants in Singapore (Henderson, 1954; Boo et al., 2006).  
 
3.3  PLANTS SELECTION AND EXTRACTION 
 
3.3.1 Plants Selection Criteria  
 
The criteria used for selecting plants for in vivo anti-malarial investigation were based 
on: (1) traditional medicinal information (ethnobotanical survey); (2) plants used orally 
as a remedy to treat malaria and/or fever (3) literature reports on plant extracts: only 
those plants that have not been pharmacologically investigated against malaria were 
chosen in this study. From nineteen medicinal plants, four were chosen to be 
investigated; Cocos nucifera L. (Arecaceae), Labisia pumila (Bl.) F.-Vill. 
(Myrsinaceae), Languas galanga Stuntz. (Zingiberaceae)  and Piper betle L. 
(Piperaceae). 
 
 
3.3.2  Plant Materials 
 
Dried plant materials of Cocos nucifera, Labisia pumila, Languas galanga and Piper 
betle were used in this study. The plant parts were selected based on the ethnobotanical 
survey. The plants have been recorded as a curative and prophylactic anti-malarial 
remedy by the respondents. The plants were dried either at 40 °C in a hot air oven or at 
room temperature and then milled. The dried plants materials were provided by 
specialized company, Ethno Resources Sdn Bhd's, Kuala Lumpur. 
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3.3.3  Extraction of Dried Plant Materials 
  
Because most of the identified anti-microorganisms aromatic and saturated organic 
compounds of plant components were acquired during the preliminary methanol 
extraction (Fransworth, 1994; Eloff, 1998; Cowan, 1999), hence, methanol solvent was 
used in this study to extract the crude materials of the plants. 500 grams of the plants 
powder materials were soaked in absolute methanol (3.5 L) for 72 hours. The extracts 
were then filtered with Whatman filter paper No.2 on a Büchner funnel and 
concentrated using a rotary evaporator to dryness at 40 °C in vacuo. The percentage 
yield (%w/w) of the Cocos nucifera, Labisia pumila, Languas galanga and Piper betle 
dry extracts were 4.19%, 3.76%, 3.27% and 8.69%, respectively. The freeze-dried 
extracts were kept at 4 °C until used.  
 
3.3.4  Plant Extracts and Control Groups Dosages Preparation 
 
Resulting extracts were not able to dissolve in the distilled water. Therefore, an orally 
non toxic dimethyl sulphoxide (DMSO) with known LD50 of 16.5-24.6 g/kg was used as 
recommendations of OECD (2001) for vehicles other than water. The crude extracts 
were dissolved in dimethyl sulphoxide and distilled water to the desired acute oral 
toxicity and anti-malarial dosages. The concentration of DMSO in the distilled water 
and the plants extract was 10%.  The methanol extracts in DMSO/distilled water was 
orally administered to mice in the test groups, whereas the control group administered 
distilled water containing 10% DMSO (Carrico et al., 2004; Thanabhorn et al., 2005; 
Hajimehdipoor et al., 2006; Mi-Hyang et al., 2006; Adeneye & Agbaje, 2008; Innocent 
et al., 2009; Ali et al., 2009; Sampaio et al., 2009; Ramazani et al., 2010; Azra et al., 
2010; Konate et al., 2011).  
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3.4 ANTI-MALARIAL ACTIVITY OF PLANTS EXTRACTS 
 
3.4.1 Animals 
 
ICR mice were obtained from the Laboratory Animal Centre of Faculty of Medicine, 
University of Malaya. On a standard pelleted feed and water ad libitum, the mice were 
kept and maintained in standard conditions. The mice were caged of 5 animals per 
group and maintained in the animal laboratory in the Faculty of Medicine in conformity 
with the international ethics of laboratory animal use and care. 
 
3.4.2 Acute Oral Toxicity (LD50) 
 
Different extract doses (300, 2000 and 5000 mg/kg) were inoculated orally to evaluate 
the acute oral toxicity according to the accepted standard described in the OECD 
guideline No 401 and 423; ―Acute oral toxicity – acute toxic class method‖ (OECD, 
1987; 2001). The females and males ICR mice were dosed at 5000 mg/kg. Animals 
extract groups that died after giving the highest dose (5000 mg/kg) were given the rest 
of the lower doses (2000, 300 mg/kg). A total of 10 mice (five females and five males) 
were tested for each extract dose (OECD, 1987). The general behaviour of the mice, 
clinical observations and mortality were monitored during the first 60 minutes after 
dosing and during the first 48 hours following dosing. The LD50 was calculated by the 
probit analysis. 
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 Particular consideration was focused on any observation of asthenia, 
piloerection, ataxia, anorexia, salivation, urination, diarrhoea, tremors, convulsions, 
lethargy, sleep and coma. Observations once daily were carried out for the remainder of 
the study. The mice were monitored for 14 days after the inoculation. On D -1, 0, 7 and 
14, body weights were recorded. The LD50 was calculated using probit regression 
analysis in the SPSS statistical package (version 13, 2004). 
 
3.4.3 Rodent Malaria 
 
Plasmodium berghei (NK65) was obtained from Universiti Kebangsaan Malaysia 
(UKM), School of Bioscience and Biotechnology and was maintained by subpassage in 
ICR mice. P. berghei strain was tolerated to 25 mg/kg total standard dose of 
chloroquine (not completely suppress the parasitaemia). This developed resistance may 
be because of the repeated passage of the parasite from the mouse to another in the 
context of maintaining the parasite strain in the laboratory (Adzu, et al., 2003; Chawira, 
1986; Okokon, et al., 2005). On the other hand, when 20 mg/kg for 4 consecutive days 
is used to cure P. berghei infected mice, it suppressed parasitaemia to non-detectable 
levels during the 4-day suppressive test, which is also evident in this study (Ishih et al., 
2006; Muregi et al., 2007). 
 
3.4.4 Parasite Inoculum 
 
A mouse having 30% parasitaemia was used as a donor to initiate the infection to the 
test mice. The blood was obtained through cardiac puncture or tail of the donor mouse. 
The blood was diluted in Alsever‘s solution and the parasitaemia was adjusted to the 
desired points. The female ICR mice, 7-8 weeks-old of about 25-28 g weight were 
infected intraperitoneally with about 10
6
 parasitized RBCs in 0.2 ml (Ishih et al., 2004).  
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 The inoculated animals were then randomized into five mice per group and 
maintained in the Animal Room, Department of Parasitology, Faculty of Medicine, 
University of Malaya, in accordance with the internationally accepted principles for 
laboratory animal‘s use and care.  
 
3.4.5 Giemsa-Stained-Blood Film Preparation 
 
The blood film was prepared from the mice tail. The mice tail end was cleansed using 
cotton moistened with 70 % v/v alcohol.  The blood drops were obtained and thin blood 
smears were made on a completely clean (grease-free) and scratch-free slide. The dried 
blood film was stained by Giemsa‘s stain. The Giemsa stain was diluted with phosphate 
buffer saline, pH 7.2 (3% solution for 30 minutes staining). The blood film was washed 
with running water, placed in a draining rack and air dried.  
 
3.4.6 Degree of Infection (Parasitaemia) 
 
The degree of infection (parasitaemia) was estimated from the Giemsa-stained thin 
blood films by observing the
 
number of parasitized RBCs in
 
9,000 RBCs (about 20-40 
monolayer microscopic fields) using the 100x oil immersion objective. The 
parasitaemia (percentage) was determined by calculation the total number of infected 
cells per microscope field against the total number of observed red cells, using the 
following formula according to Peters (1965), Ryley and Peters (1970). 
                                                                              
       The parasitaemia percentage % = 
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3.4.7  The Percentage of Suppression (anti-malarial activity) 
  
The effectiveness of the extracts was determined by calculating the degree of 
suppression. The suppression of parasitaemia (%) was determined as stated by Peters 
(1965), Ryley and Peters (1970), Peter and Robinson (1992) as follows: 
 
Average percentage chemosuppression was calculated as 
    
   
 
  
Where, A is the mean percentage parasitaemia in the control group and B is the mean 
percentage parasitaemia in the test group. 
 
3.4.8 In Vivo Anti-Malarial Screening Assays 
 
A series of in vivo anti-malarial assays i.e., 4-day suppressive test, curative and 
prophylactic methods (APPENDIX E) were carried out to assess the in vivo anti-
malarial activities of the plant extracts at 50, 100, 200 and 400 mg/kg doses (Fidock et 
al., 2004; Elufioye & Agbedahunsi, 2004) as compared to control groups treated with 
0.2 mL distilled water (containing 10% DMSO, the solvent of the test extracts) and 
reference groups treated with chloroquine 20 mg/kg or pyrimethamine 1.2 mg/kg. 
Pyrimethamine was used during the prophylactic assay since it has a better 
chemoprophylactic activity than chloroquine (Bradley-Moore et al., 1985). Malaria 
infection was established in female ICR mice by the intraperitoneal administration of 
donor female ICR mouse blood containing about 1 × 10
6
 parasites.  
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i. 4-day suppressive activity (early malaria infection) 
 
Suppressive activity of the extract during early malaria infection was assessed as 
described early by Peters and Robinson (1992). The female ICR mice were 
intraperitoneally infected on the first day (D 0), with 0.2 mL blood containing 1×10
6
 P. 
berghei parasitized RBCs. 
 
 The infected mice were randomized into 16 extracts groups, one control and one 
reference drug groups of five mice each. Three hours after infection, the extracts-treated 
groups were treated orally with 50, 100, 200 and 400 mg/kg doses of the extracts. 
Chloroquine and distilled water (10% DMSO) were administered to the reference drug 
and control groups, respectively. The extracts and drug treatments continued daily (D0 
to D3) for four days. From tail blood, thin films were prepared on D4 (the 5th day). The 
blood films from of each mouse were stained with Giemsa and the percentage of 
suppression was then calculated. 
 
ii. Curative activity (established malaria infection) 
 
The curative test was evaluated according to the method explained by Ryley & Peters 
(1970) and Saidu et al. (2000). The mice were selected and 0.2 mL of inoculum (1x10
6 
P. berghei) was given to each mouse (i.p.). Seventy two hours later, the extract-tested 
groups were orally administered with 50, 100, 200 and 400 mg/kg doses of the extracts. 
Chloroquine and distilled water (10% DMSO) were administered to the reference drug 
and control groups, respectively. The extract and drug treatments were continued for 
five days. From tail blood of each mouse, thin blood films were prepared for five days. 
The mean differences between the test groups and control were evaluated on D6 
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according to Saidu et al. (2000). The survival time of extract-tested, reference drug and 
control groups were recorded over a period of 30 days, where the mean survival time 
differences between the test groups and control were determined. 
 
iii. Prophylactic activity (residual malaria infection) 
 
The prophylactic activity of the plants during residual malaria infection was assessed 
according to the technique described by Peters (1965). For three days (D0 to D2), each 
experimental animal in the studied groups was administered orally at 50, 100, 200 and 
400 mg/kg of the plants crude extract, pyrimethamine and distilled water (10% DMSO) 
were administered to the reference group, and control group, respectively. The 
experimental mice were then intraperitoneally infected with 1×10
6
 P. berghei on the 
fourth day. Three day after infection, the blood films from of each mouse were stained 
with Giemsa and the percentage of suppression was then calculated. 
 
3.4.9 Phytochemical Screening 
 
Standard qualitative methods for determination of chemical constituents in the plants 
extract were performed to expose the presence of alkaloids, anthraquinones, flavonoids, 
terpenoids, tannins, saponins, steroids and glycosides according to Hymete (1986) 
Trease & Evans (1989) and Sofowora (1993). 
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i. Test for alkaloids 
 
Half a gram of each plant extract in ten mL acid alcohol were boiled for 5 minutes and 
filtered. Two mL of dilute ammonia followed by five mL of chloroform were added to 
the filtrate and mix softly. To the chloroform layer ten mL of acetic acid were added. To 
the mixture, Draggendorff‘s reagent was added. The presence of alkaloids was indicated 
by the appearance of a reddish brown precipitate. 
 
ii. Test for anthraquinones 
 
In ten mL of sulfuric acid, half a gram of each plant extract was boiled for five minutes. 
The hot mixture was then filtered. Five mL of chloroform were added to the filtrate and 
mix. In another tube, one mL of dilute ammonia was added to the chloroform layer. The 
presence of anthraquinones was indicated by colour changes of the mixture to brown. 
 
iii. Test for terpenoids (Salkowski Test) 
 
Two mL of chloroform was added to half a gram of each plant extract. Three mL of 
concentrated sulfuric acid was carefully added to the mixture. The presence of 
terpenoids was revealed by the presence of a reddish brown layer. 
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iv. Test for flavonoids 
 
Half a gram of each plant extract was heated for three minutes in ten mL of ethylacetate 
and filtered. One mL of 1 % ammonia solution was added to four mL of the filtrate. 
After giving some time for the layers to separate in the mixture, a yellow colour in the 
ammonia layer is regards as an indication of the presence of flavonoids. 
 
v. Test for saponins (Froth test) 
 
 
In five mL of distilled water, half a gram of each plant extract was boiled for five 
minutes. The hot mixture was then filtered and further four mL of distilled water was 
added to one mL of the filtrate. The solution was mixed strongly for 30 minutes. The 
presence of saponins was revealed by the persistence of a sable forth more than 30 
minutes. 
 
vi. Test for tannins 
 
In five mL of 45 % ethanol, two 2 g of each plant extract was boiled with for five 
minutes. The cooled mixture was then filtered.  Three drops of lead sub-acetate solution 
was added to one mL of the filtrate. Formation of a cream gelatinous precipitate 
indicated the presence of tannins. 
 
vii. Test for steroid 
 
To two mL of chloroform, half a gram of each plant extract was added. To the mixture 
concentrated sulfuric acid was added (carefully). The presence steroid was indicated by 
the formation of a reddish brown layer at the interface. 
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viii. Test for glycosides 
 
To half a gram of each plant extract, five mL of dilute sulfuric acid was added and 
boiled for 15 minutes. Neutralization of the cooled mixture was performed with 20 % 
potassium hydroxide. A mixture (ten mL) of identical quantity of Fehling‘s solution A 
and Fehling‘s solution B was added.  The mixture was then boiled for five minutes. The 
presence of glycosides was indicated by the formation of a red precipitate (more dense). 
 
3.4.10 Antioxidant Capacity 
 
Determination of antioxidant capacity of the plants extract was carried according to 
Gerhäuser et al. (2003). The plants extract free radical scavenging activity against 
DPPH (1,1-diphenyl-2-picrylhydrazyl), the stable artificial free radical, was determined 
photometrically with spectrophotometer. Different concentrations (1.56, 3.13, 6.25, 12.5 
and 25 μg/mL) prepared with DPPH radical solution were incubated in a 96-well 
microplate and read at 515 nm for 3 hours at 20-min intervals. Ascorbic acid and gallic 
acid were used for comparison. The DPPH radical scavenging activity of the plants 
extract was expressed as the percentage of scavenging of the DPPH by the extract and 
was calculated as follows: 
 
DPPH radical scavenging activity (%) = {[Ab-Aa]/Ab} × 100 
Where Ab is the absorption of the blank sample, and Aa is the absorption of the sample. 
Each test was carried out three times and the mean ± S.E.M. was calculated. The DPPH 
% was presented as μg /mL of concentration. 
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3.5 DATA MANAGEMENT AND ANALYSIS 
 
The data obtained were analyzed using Statistical Program for Social Scientists (SPSS 
13.0.) and Microsoft Office Excel 2007 statistical analysis.  
 
 The Chi-square test was used to examine the KAP differences between 
aboriginal and rural participants for each of the outcome variables and P ≤ 0.05 was 
considered as the level of significance. Before data entry and analysis, questionnaires 
were checked for coding errors, completeness and consistency. 
 
 The information obtained in the course of the ethnobotanical interviews was 
analyzed using the following parameters according to Asase et al. (2005): 
1. Taxonomic diversity, preparation, application and parts of the plant used. 
2. The percentage of respondent‘s knowledge (PRK) regarding the use of plants species 
to treat malaria was estimated as following: (No. of interviewed people citing 
species/total No. of interviewed people using plants) ×100. 
3. Preference ranking (PR), in this parameter the plants were ranked to three levels (one, 
two and three) according to their efficiency in the treatment of malaria by the 
respondents. A value of three (3) was given for the most effective plant.   
 
 The iv vivo anti-malarial activity of the test extracts, reference drugs and control 
groups at different doses in mice parasitized with P. berghei were expressed as 
percentage (%) for the suppression of parasitaemia. Parasitaemia were expressed as 
mean ± S.E.M. (n = 5) and significance compared to controls. The Student‘s t-test and 
ANOVA were applied to examine the differences between the test and control groups. 
Differences between means at 5% level (P ≤ 0.05) were considered significant 
(effective).  
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 DPPH radical scavenging activity results represent means (± S.E.M) of 
triplicates of the different concentrations analyzed. 
 
3.6 ETHICAL CONSIDERATION 
 
The protocol of this study has been approved by the Medical Research Committee of the 
University of Malaya Medical Centre, and the Department of aboriginal Affairs, 
Ministry of Rural Development. Ethical approval was obtained from the ethical 
committee of the Faculty of Medicine, University of Malaya and Jabatan Hal Ehwal 
Orang Asli (JHEOA), Department of Aboriginal Affairs, Ministry of Rural 
Development, prior to study commencement.  
 
 Permission and approval for animal studies were obtained from the Faculty of 
Medicine, Animal Ethics committee, University of Malaya dated 05 June 2009 (Ref. 
No. PAR/05/6/2009/AHAA-R). 
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CHAPTER IV 
 
RESULTS  
 
4.1  COMMUNITY’S AWARENESS REGARDING MALARIA 
 
4.1.1 General Characteristics of Participants 
 
Out of the 260 households that participated in this survey, questionnaires were only 
completed for 223 households (100 forest-aboriginal and 123 rural). Table 4.1 shows 
the general socio-demographic characteristics of the study population. Overall, 10% of 
the aboriginal households had previously suffered from malaria compared to 1.6% of 
rural households. Almost half of the aboriginal participants had no formal education, 
and the proportion of men with formal education was significantly higher than that of 
women (χ2=21.549, P < 0.001). In contrast, almost all the rural participants had formal 
education and the proportion of women with formal education was significantly higher 
than that of men (χ2=4.922, P = 0.027). 
 
4.1.2 Malaria Knowledge 
 
Data about the participants‘ knowledge and attitudes to malaria are shown in Table 4.2. 
About half of the aboriginal participants believed that malaria is transmitted by 
mosquito bites and this was significantly associated with the educational level 
(χ2=4.244, P = 0.039). Aboriginal participants who had previously been infected with 
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malaria showed better knowledge of the symptoms of malaria than those with no history 
of infection (χ2=6.810, P = 0.009).  
 
 On the other hand, the majority (86.2%) of the rural participants have knowledge 
of malaria as a disease and 70.7% of them believed that malaria is transmitted through 
the bite of mosquitoes and this was found to be influenced by their level of education; 
participants who had better education showed better knowledge about malaria as a 
disease and malaria symptoms (χ2=24.037, P < 0.001; χ2=4.416, P = 0.036 
respectively). Moreover, Malay participants showed a higher level of knowledge about 
malaria transmission than Chinese and Indian (χ2=6.234, P = 0.013). The findings also 
showed that attitudes towards the severity of malaria were significantly higher among 
aboriginal participants who had previously been infected with malaria (χ2=4.421, P = 
0.036). 
 
4.1.3 Malaria Treatment-Seeking Behaviour and Prevention 
 
Data about treatment-seeking behaviour and prevention methods are shown in Table 
4.3. The vast majority of the rural participants (95.1%) indicated that they would seek 
treatment from health centre and this was found to be associated significantly with the 
educational level and age of the participants (χ2=6.236, p = 0.013; χ2=9.856, p = 0.002 
respectively). Similarly, the educational level, age and race of the rural participants 
were associated significantly with the practicing of effective preventive measures 
(χ2=4.634, P = 0.031; χ2=5.483, P = 0.019; χ2=7.965, P = 0.019, respectively). 
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 Overall, the rural participants showed a higher knowledge regarding malaria and 
its transmission than the Aborigines (χ2=6.746, P = 0.009; χ2=10.006, P = 0.002, 
respectively) (Table 4.2). On the contrary, the aboriginal participants showed a higher 
practices in their treatment-seeking behaviour for treating febrile diseases, both in terms 
of the use of medicinal plants (χ2=5.225, P = 0.022) or belief in witchcraft and sorcery 
(χ2=16.980, P < 0.001) (Table 4.3).  
 
 Regarding the knowledge about the symptoms of malaria, the attitude towards 
severity of the disease as well as the use of mosquito bednets, the two communities did 
not show significant differences. However, the knowledge and practice of different 
preventive measures to combat malaria such as insecticides and the elimination of 
breeding areas was significantly higher among the rural population than the Aborigines 
(χ2=23.136, P < 0.001). 
 
 However, the rural population showed significant differences higher than the 
Aborigines in the combat against malaria in different preventive measures such as the 
use of insecticides and elimination of mosquito breeding areas (χ2=23.136, P < 0.001). 
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Table 4.1: Socio-demographic characteristics of the participants 
Characteristics 
population 
Forest-aboriginal (n = 100) 
n (%) 
Rural (n = 123) 
n (%) 
Age (years)   
      18-40 76 (76.0) 75 (61.0) 
      >40     24 (24.0) 48 (39.0) 
Sex   
      Males 38 (38.0) 46 (37.4) 
      Females 62 (62.0) 77 (62.6) 
Religion   
      Non-religious 99 (99.0) 0 (0.0) 
      Muslim 1 (1.0) 74 (60.1) 
      Buddhist 0 (0.0) 36 (29.3) 
      Hindu 0 (0.0) 13 (10.6) 
Education   
      None   38 (38.0) 6 (4.9) 
      Kindergarten 5 (5.0) 2 (1.6) 
      Primary school 49 (49.0) 57 (46.3) 
      Secondary school  8 (8.0) 51 (41.5) 
      Tertiary 0 (0.0) 5 (4.1) 
      University    0 (0.0) 2 (1.6) 
Occupation   
      Working 31 (31.0) 38 (30.9) 
      Non-working 35 (35.0) 36 (29.3) 
      Housewife   34 (34.0) 47 (38.2) 
      Students 0 (0.0) 2 (1.6) 
Races   
     Aborigine 100 (100.0) 0 (0.0) 
      Malay 0 (0.0) 74 (60.1) 
      Chinese 0 (0.0) 36 (29.3) 
      Indian 0 (0.0) 13 (10.6) 
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Table 4.2: Participant‘s knowledge about malaria transmission and symptoms, and 
attitudes towards malaria severity 
 
 
 
Variables 
Population 
χ2 
significance 
Forest-aboriginal 
 (n = 100) 
n (%) 
Rural  
(n = 123) 
n (%) 
Transmission of 
malaria 
   
Mosquito bites   50 (50.0) 87 (70.7) P < 0.01 
Use of stagnant 
water 
46 (46.0) 6 (4.9) P < 0.001 
From forest 17 (17.0) 0 (0.0) P < 0.001 
Human-to- human  7 (7.0) 4 (3.3) ns 
From weather/sun  3 (3.0) 0 (0) ns 
No knowledge 16 (16.0) 26 (21.1) ns 
Symptoms of malaria    
Fever 76 (76.0) 95 (77.2) ns 
Chill and rigor 56 (56.0) 27 (22.0) P < 0.001 
Headache   30 (30.0) 24 (19.5) ns 
Vomiting 11 (11.0) 16 (13.0) ns 
Body pain/weakness 10 (10.0) 7 (5.7) ns 
Loss of appetite 9 (9.0) 9 (7.3) ns 
Red rash 8 (8.0) 18 (14.6) ns 
Abdominal discomfort 2 (2.0) 0 (0.0) ns 
No knowledge 13 (13.0) 18 (14.6) ns 
Is malaria a serious 
disease? 
   
Yes 72 (72.0) 93 (75.6) ns 
No 10 (10.0) 13 (10.6)  
No knowledge 18 (18.0) 17 (13.8)  
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Table 4.3: Participant‘s practices in malaria treatment-seeking behaviour and prevention 
methods 
 
 
 
 
 
Variables 
Population  
Forest-aboriginal  
(n = 100) 
n (%) 
Rural  
(n = 123) 
n (%) 
χ2 
significance 
Treatment-seeking behavior  
Go to clinic as a first line 
activity (within 24hrs of fever 
onset) 
65 (65.0) 117 (95.1) P < 0.001 
Use plant remedies   28 (28.0) 19 (15.4) P < 0.05 
Believe in Witchcraft to treat 
malaria 
13 (13.0) 0 (0.0) P < 0.001 
Take anti-malarial/anti-
pyretic medicine 
0 (0.0) 6 (4.9) P < 0.05 
Malaria prevention methods  
Use of mosquito bed nets 63 (63.0) 76 (61.8) ns 
Keep the house/surroundings  
clean 
30 (30.0) 46 (37.4) ns 
Elimination of breeding sites 0 (0.0) 8 (6.5) P < 0.001 
Use of insecticide /spraying 3 (3.0) 33 (26.8) P < 0.001 
Fumigation by smoke 7 (7.0) 28 (22.8) P < 0.01 
Use of anti-malarials 1 (1.0) 8 (6.5) P < 0.05 
Use of medicinal plants 10 (10.0) 6 (4.9) ns 
No knowledge 21 (21.0) 23 (18.7) ns 
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4.2 ETHNOBOTANICAL STUDY ON ANTI-MALARIAL PLANTS 
 
The use of anti-malarial plants was significantly higher among the aboriginal 
community (χ2=5.225, P=0.022). Of the 223 interviewed respondents, 28% and 15.4% 
of the aboriginal and rural participants had tried self medication with anti-malarial plant 
remedies to cure or prevent malaria infections, respectively. Traditional healers are 
rarely found in the rural areas. However, some of the religious leaders such as imams of 
mosques and temples priests are practicing and prescribing the traditional plants to the 
people. For instance, Azadirachta indica Juss. (locally known as Margosa) has been 
mentioned by an Indian priests who stated that this plant has its folkloric background in 
the treatment of fever and malaria in the ayurvedic medicine. On the other hand, Nigella 
sativa L. (locally known as Jintan hitam), which has its religious background in the 
prophetic medicine, has been mentioned by a Malay imam of mosque. 
 
 As shown in Table 4.4, a total of 19 species in 17 families used to treat malaria 
or fever were identified. Eleven of the vouchers of the plants that were identified by a 
plant taxonomist, have been previously collected and deposited at the Herbarium of the 
University of Malaya for the purposes of different studies at the university. While eight 
plants namely, Cassia siamea L., Cocos nucifera L., Languas galanga Stuntz., Nigella 
sativa L., Ocimum tenuiflorum L., Phyllanthus niruri L.,  Piper betle L., Hibiscus rosa-
sinensis L., were deposited for the first time during this study. The collection of plants 
at the Rimba Ilmu Botanic Garden of the University of Malaya, includes a large number 
of medicinal plants. The plants vouchers at the Herbarium of the University of Malaya 
are shown in the Figure 4.1. 
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Table 4.4: Plant species identification and voucher numbers 
Species Family voucher numbers 
   
1. Azadirachta indica Juss. Meliaceae KLU 33205 
2. Brucea javanica Merr.  Simaroubaceae KLU 34932 
3. Cassia siamea L.  Fabaceae   KLU 46621 
4. Cocos nucifera L.  Arecaceae KLU 47212 
5. Eurycoma longifolia Jack  Simaroubaceae KLU 03593 
6. Labisia pumila (Bl.) F.-Vill.  Myrsinaceae KLU 09386 
7. Languas galanga Stuntz.   Zingiberaceae KLU 46619 
8. Lansium domesticum Corr.  Meliaceae KLU 44528 
9. Morinda citrifolia L.  Rubiaceae KLU 45405 
10. Nigella sativa L.  Ranunculaceae KLU 47213 
11. Ocimum tenuiflorum L.  Lamiaceae KLU 46618 
12. Phyllanthus niruri L.   Phyllanthaceae KLU 46617 
13. Piper betle L.  Piperaceae KLU 46620 
14. Hibiscus rosa-sinensis L.  Malvaceae KLU 46616 
15. Tinospora crispa L.  Menispermaceae KLU 45568 
16. Aeschynanthus sp. Jack  Gesneriaceae KLU 20482 
17. Alstonia angustiloba Mig.  Apocynaceae KLU 03364 
18. Curcuma domestica L.  Zingiberaceae KLU 41829 
19. Elateriospermum tapos Bl.  Euphorbiaceae KLU 42028 
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Figure 4.1: Azadirachta indica Juss. (KLU 33205), Brucea javanica Merr. (KLU 
34932), Cassia siamea L. (KLU 46621), Cocos nucifera L. (KLU 47212). 
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Figure 4.1 continued: Eurycoma longifolia Jack (KLU 03593), Labisia pumila (Bl.) F. 
Vill. (KLU 09386), Languas galanga Stuntz. (KLU 46619),  Lansium 
domesticum Corr. (KLU 44528). 
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Figure 4.1 continued: Morinda citrifolia L. (KLU 45405), Nigella sativa L. (KLU 
47213), Ocimum tenuiflorum L. (KLU 46618), Phyllanthus niruri L. (KLU 46617). 
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Figure 4.1 continued: Piper betle L. (KLU 46620), Hibiscus rosa-sinensis L. (KLU 
46616), Tinospora crispa L. (KLU 45568), Aeschynanthus sp. Jack (KLU 20482). 
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Figure 4.1 continued: Alstonia angustiloba Mig. (KLU 03364), Curcuma domestica L. 
(KLU 41829) and Elateriospermum tapos Bl. (KLU 42028). 
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 The majority of the plant species (89.5%, 17/19) were identified through the 
interviews with the aboriginal and rural people. In spite of only 31.6% (6/19) of the 
plant species being identified through the interviews with the traditional healers, most of 
them got the highest preference ranking. Some plants were mentioned in more than one 
interviewed group and Eurycoma longifolia was the only species that was mentioned in 
all three interviewed groups. However, most of the identified plant species were 
mentioned by only one respondent (PRK 1.8). The plant species with higher PPK values 
were Eurycoma longifolia (PRK 15.8) followed by Labisia pumila (PRK 14.0) and 
Tinospora crispa (PRK 7.0), respectively (Table 4.5).  
 
 All of the identified plant remedies are used for curative purposes to cure 
malaria, and six plant species are used as curative and prophylactic remedies. Data 
obtained from the users of anti-malarial plants showed that 73.7% of the anti-malarial 
plant remedies were obtained from trees and herbs (Table 4.6).  
 
 Different parts of the plants were used in the preparation of anti-malarial plant 
remedies. In most of the species (63%), the remedies were obtained from the leaves and 
roots. Fifteen plants are used orally as decoctions or infusions, mainly three times daily 
until malaria is cured. Of the 15 plants used orally, the anti-malarial activity of four 
plants, C. nucifera, L. pumila, L. galanga and P. betle four plants are non-existent in the 
literature (Table 4.7). 
 
 Four plants decoctions are applied externally during bathing in combination of 
more than one species. In some instances, they are applied as compresses to the 
abdominal area accompanied by chanting some religious words.  
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Table 4.5 Interviewed groups, percentage and preference ranking of plants species 
Species (voucher numbers) Interviewed groups PRK PR 
 AH  RH TH   
Azadirachta indica Juss.  * * 3.5 3 
Brucea javanica Merr.   * 1.8 3 
Cassia siamea L.   *  1.8 1 
Cocos nucifera L.   *  1.8 1 
Eurycoma longifolia Jack * * * 15.8 3 
Labisia pumila (Bl.) F.-Vill. *  * 14.0 2 
Languas galanga Stuntz.  * *  3.5 2 
Lansium domesticum Corr.   *  1.8 1 
Morinda citrifolia L.  *   1.8 1 
Nigella sativa L.    * 1.8 2 
Ocimum tenuiflorum L.  *  1.8 1 
Phyllanthus niruri L. *   1.8 1 
Piper betle L.  * *  3.5 2 
Hibiscus rosa-sinensis L. *   1.8 1 
Tinospora crispa L.  * * 7.0 3 
Aeschynanthus sp. Jack  *   1.8 1 
Alstonia angustiloba Mig.  *   1.8 1 
Curcuma domestica L.  *   3.5 1 
Elateriospermum tapos Bl.  *   1.8 1 
AH: Aboriginal households, RH: rural households, TH: traditional healers, PRK: 
percentage of respondents knowledge, PR: preference ranking. 
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Table 4.6: Application, local names, growth forms and purpose of species of the plants 
Species/Application Local name Growth 
form 
Purpose 
Plants used orally    
Azadirachta indica Margosa Tree Curative 
Brucea javanica Lada pahit Tree Curative 
Cassia siamea Johor Tree Curative 
Cocos nucifera  Kelapa  Tree Curative, Prophylactic 
Eurycoma longifolia  Tongkat Ali Shrub Curative, Prophylactic 
Labisia pumila Kacip Fatimah Herb Curative, Prophylactic 
Languas galanga  Lengkuas Herb Curative 
Lansium domesticum Langsat Tree Curative 
Morinda citrifolia Peremuh/ Mengkudu  Tree Curative 
Nigella sativa Jintan hitam/ 
Habatulsawda 
Herb Curative, Prophylactic 
Ocimum tenuiflorum   Tulsi Herb Curative 
Phyllanthus niruri Dukung anak Herb Curative 
Piper betle  Sirih/Serih Liana Curative, Prophylactic 
H. rosa -sinensis Bunga Raya  Shrub Curative 
Tinospora crispa Putarwali/Batang Wali Shrub Curative, Prophylactic 
Plants used externally    
Aeschynanthus sp. Sambuk Shrub Curative 
Alstonia angustiloba Pulai getah Tree Curative 
Curcuma domestica  Kunyit Herb Curative 
Elateriospermum tapos Perah/parah Tree Curative 
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Table 4.7: Parts used, preparation and anti-malarial reported in the literatures  
Species/Applicatio
n 
Part used Preparation Anti-malarial reported in the 
literatures 
Plants used orally    
A. indica Leaves Decoction (Obaseki and Fadunsin, 1982; 
Devi et al., 2001; Isah et al., 
2003) 
B. javanica Fruits, leaves  Infusion (Pavanand et al., 1986) 
C. siamea Stem bark Decoction (Ajaiyeoba et al., 2007) 
C. nucifera  White flesh (fruit) Infusion Not reported in the literature 
E. longifolia  Root  Decoction  (Hooi et al., 1995; Ping-Chung 
et al., 2003; Kit-Lam et al., 
2004) 
L. pumila Leaves Decoction Not reported in the literature 
L. galanga (syn. 
Alpinia galanga) 
Rhizome Decoction Not reported in the literature 
L. domesticum Peel and bark Infusion (Yapp & Yap, 2003; Saewan et 
al., 2006) 
M. citrifolia Leaves and fruits Decoction (Ancolio et al., 2002) 
N. sativa Seeds Infusion (Abdulelah & Zainal-Abidin, 
2007; Wan Omar et al., 2007) 
O. tenuiflorum 
(syn. O. sanctum)  
 Leaves and seed Decoction (Devi et al., 2001. Wan Omar et 
al., 2007) 
P. niruri Whole plants Decoction (Tona et al., 2001) 
P. betle  Leaves Chewing  Not reported in the literature 
H. rosa -sinensis Flowers Infusion (Popp et al., 1967) 
T. crispa Stems, leaves or roots   Decoction  (Sahidan et al., 1994; Nik-Najib 
et al., 1999; Wan-Omar et al., 
2007) 
 
 
 
 
 
 
 
 
 
 
 94 
 
4.3 ANTI-MALARIAL ACTIVITY OF THE PLANTS EXTRACTS 
 
The four selected plants were investigated at the same time, conditions and controls for 
each test are specified below  
 
4.3.1 Cocos nucifera L. 
 
i. Phytochemical screening of C. nucifera white flesh 
 
Phytochemical screening of the methanol extract of C. nucifera white flesh revealed the 
presence of terpenoids, tannins, steroids and glycosides.  
 
ii. Radical scavenging activity of C. nucifera white flesh 
 
The white flesh extract of C. nucifera showed a weak DPPH radical scavenging activity. 
At 1.56 - 25 µg/ml, the scavenging abilities of the methanol extract on DPPH radicals 
were 9.352%, 8.15%, 7.69%, 1.91% and 5.52%, respectively (Figure 4.2). Ascorbic acid 
and gallic acid showed strong scavenging abilities reaching 72.74 and 73.79% at 25 
µg/ml, respectively.  
 
iii. Acute oral toxicity of C. nucifera white flesh 
 
No effects of toxicity or mortalities were recorded in any of the 10 animals post dosing 
and during the observation period (14 days). All animals gained body weight by D 7 and 
on the end of the experiment (Table 4.8), the tests and control groups did not show any 
significant differences. Based on the above mentioned results, the acute oral LD50 in 
mice of the test extract was found to be in excess of 5000 mg/kg. 
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Figure 4.2:  DPPH scavenging % activity of C. nucifera white flesh methanol extract 
 
 
Table 4.8: Body weight gain of mice receiving 5000 mg/kg of C. nucifera white flesh 
methanol extract 
 
Mice groups Mean group weight (g) ± S.D. (g); n=5 Mean weight 
gain (g); n=5 
 D1 D0 D7 Day 14  
Control male 28.00 ± 1.11 
 
27.98 ± 1.28 30.52 ± 1.90 
 
31.80 ± 1.99 
 
3.80 ± 1.93 
 
 Test male 27.66 ± 2.42 
 
27.98 ± 2.47 
 
30.60 ± 2.53 
 
31.60 ± 2.41 
 
3.94 ± 1.94 
 
Control  female 22.44 ± 0.42 22.70 ± 0.37 24.40 ± 1.07 25.30 ± 0.72 2.86 ± 1.37 
Test female 23.38 ± 0.85 
 
23.50 ± 0.87 
 
25.32 ± 1.00 
 
 
26.04 ± 1.11 
 
2.66 ± 1.33 
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iv. Suppressive anti-malarial activity of C. nucifera white flesh 
 
C. nucifera white flesh methanol extract produced a dose-dependent chemotherapeutic 
activity in the 4-day suppressive test.  Chemosuppression effects of 44.71%, 56.86%, 
79.61% and 83.73% were exhibited for the 50, 100, 200 and 400 mg/kg extract doses. In 
comparison with the control, the 100, 200 and 400 mg/kg doses showed significant anti-
malarial activity during the early malaria infection (P < 0.05) (Table 4.9). 
 
v. Curative anti-malarial activity of C. nucifera white flesh 
 
The methanol white flesh extract of C. nucifera exhibited significant (P < 0.05) dose 
dependent reductions in parasitaemia for all the extract doses in comparison with the 
control. A daily increases in parasitaemia reaching 9.60 % on D6 of infection was 
exhibited by the control group (Figure 4.3). The mean parasitaemia for the treated 
groups on D6 of infection were 5.90%, 4.40%, 3.20% and 3.00 for 50, 100, 200, 400 
mg/kg, respectively (Table 4.10). On the other hand, the mice that received high doses 
of the extract during the established malaria infection showed a higher mean survival 
time during a period of 30 days than those received the lower concentrations. The mice 
treated with 20 mg/kg of the reference drug (chloroquine) exhibited a mean survival 
time of 27.20 days. The test mice treated with the extract at 50, 100, 200 and 400 
mg/kg/day showed 13.80, 14.60, 15.20, and 15.60 mean survival time (days), 
respectively, the increase in the mean survival time were not significant. The control 
group had a mean survival time of 13.6 days (Table 4.11).  
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Table 4.9: Suppressive anti-malarial activity of C. nucifera white flesh methanol extract 
 
* P ≤ 0.05 compared to the control group. 
 
 
 
Table 4.10: Curative anti-malarial activity of C. nucifera white flesh methanol extract 
 
 Extract/drug Dose 
 
Parasitaemia% 
(D6) 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 9.60 ± 0.93 
 
White flesh extract 50 mg/kg 5.90 ± 0.86 38.54* 
 
100 mg/kg 4.40 ± 0.97 54.17* 
 
200 mg/kg 3.20 ± 0.51 66.67* 
 
400 mg/kg 3.00 ± 0.51 68.57* 
Chloroquine 20 mg/kg 00.00 100 
* P ≤ 0.05 compared to the control group. 
 
 
 Extract/drug Dose 
Parasitaemia% 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 5.1 ± 0.33  
White flesh extract 50 mg/kg 2.82 ± 0.78 44.71 
  100 mg/kg 2.20 ± 0.49 56.86* 
  200 mg/kg 1.04 ± 0.75 79.61* 
  400 mg/kg 0.83 ± 0.47 83.73* 
Chloroquine 20 mg/kg 00.00 100 
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Figure 4.3: Comparison of parasitaemia chemosuppression of C. nucifera white flesh 
extract-treated groups and control from D3 until D7 after infection 
 
 
Table 4.11: Mean survival time of mice treated with C. nucifera white flesh methanol 
extract 
 
Extract/drug Dose Mean survival time  
± S.E.M. (n=5) 
 
Control 0.2 mL 13.60 ±0.51 
White flesh extract 50 mg/kg 13.80 ±1.69 
 100 mg/kg 14.60 ±1.21 
 200 mg/kg 15.20 ±0.66 
 400 mg/kg 15.60 ±1.36 
Chloroquine 20 mg/kg 27.20 ± 1.11* 
* P ≤ 0.05 compared to the control group. 
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vi. Prophylactic anti-malarial activity of C. nucifera white flesh 
 
Table 4.12 presents the description of the residual infection. C. nucifera showed dose 
dependent prophylactic anti-malarial activity during.  It exerted 30.43%, 43.48%, 
56.52% and 73.91% suppressions, respectively.  C. nucifera showed significant (P < 
0.05) prophylactic anti-malarial activity during the residual malaria infection by the 
highest concentrations of the extracts, 200 and 400 mg/kg doses. The 50, 100 and 200 
doses of the extract exhibited lower suppressions when compared with the 400 dose, 
which showed a prophylactic activity closed to the standard drug (Table 4.12). 
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Table 4.12: Prophylactic anti-malarial activity of C. nucifera white flesh methanol 
extract 
 
Drug/extract Dose Parasitaemia% 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 4.60 ± 0.51   
White flesh extract 50 mg/kg 3.20 ± 0.49 30.43 
  100 mg/kg 2.60 ± 0.81 43.48 
  200 mg/kg 2.00 ± 0.45 56.52* 
  400 mg/kg 1.20 ± 0.20 73.91* 
Pyrimethamine 1.2 mg/kg 1.24 ± 0.47 73.04* 
* P ≤ 0.05 compared to the control group. 
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4.3.2 Labisia pumila (Bl.) F.-Vill. 
 
i. Phytochemical screening of L. pumila leaves 
 
The presence of terpenoids, flavonoids, tannins, steroids and saponin was indicated 
through the phytochemical screening of L. pumila leaves methanol extract. 
 
ii. DPPH radical scavenging activity of L. pumila leaves 
 
 
L. pumila showed moderate DPPH radical scavenging activity. At 1.56 - 25 µg/ml, the 
scavenging abilities of the methanol extract on DPPH radicals were 6.82%, 8.80%, 
17.21%, 23.03% and 40.66%, respectively (Figure 4.4). Ascorbic acid and gallic acid 
showed strong scavenging abilities reaching 72.74 and 73.79% at 25 µg/ml, 
respectively.  
 
iii. Acute oral toxicity of L. pumila leaves 
 
 
No effects of toxicity or mortalities were recorded in any of the 10 animals post dosing 
and during the observation period (14 days). All animals gained body weight by D 7 and 
at on the end of the experiment, the tests and control groups did not show any 
significant differences (Table 4.13). Based on the above mentioned results, the acute 
oral LD50 in mice of the test extract was found to be in excess of 5000 mg/kg. 
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Figure 4.4:  DPPH scavenging % activity of L. pumila leaves methanol extract 
 
 
 
Table 4.13: Body weight gain of mice receiving 5000 mg/kg of L. pumila leaves 
methanol extract 
 
Mice groups Mean group weight (g) ± S.D. (g); n=5 Mean weight 
gain (g); n=5 
 D-1 D0 D7 Day 14  
Control male 28.00 ± 1.11 
 
27.98 ± 1.28 30.52 ± 1.90 
 
31.80 ± 1.99 
 
3.80 ± 1.93 
 
 Test male 28.16± 0.86 
 
28.74± 0.98 
 
30.12± 1.32 
 
31.3± 1.23 
 
3.14± 1.41 
 
Control female 22.44 ± 0.42 
 
22.70 ± 0.37 
 
24.40 ± 1.07 
 
25.30 ± 0.72 
 
2.86 ± 1.37 
 
Test female 22.08± 1.08 
 
22.28± 1.26 
 
23.62± 1.06 
 
 
24.42± 1.01 
 
2.34± 1.11 
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iv. Suppressive anti-malarial activity of L. pumila leaves 
 
The in vivo anti-plasmodial activity during the early malaria infection showed that only 
the 400 mg/kg dose has a significant anti-malarial activity (P < 0.05). A dose-dependent 
chemosuppressive activity which ranged between 19.61% and 50.94 % in all groups of 
mice has been exhibited (Table 4.14).  
 
v. Curative anti-malarial activity of L. pumila leaves 
 
L. pumila leaves showed active anti-malarial activity of more than 30% reduction of 
parasitaemia by the 400 mg/kg dose. However, no significant activity has been revealed.  
Chemosuppression effects on D6 were shown for the doses of the extract (Table 4.15). 
Comparison of parasitaemia chemosuppression of the extract-treated groups and control 
from D3 until D7 after infection is shown in Figure 4.5. The mean survival did not show 
significant results for this plant extract (Table 4.16). 
 
 
vi. Prophylactic antimalarial activity of L. pumila leaves 
 
The highest percentage of parasitaemia reduction caused by the leaves extract of L. 
pumila in residual malaria infection was 36.96% for the 400 mg/kg extract dose. Again, 
the prophylactic test did not show any significant results. In the Table 4.17, prophylactic 
suppression values of 02.17%, 13.04%, 21.74% and 36.96 % was exerted for the 
corresponding doses of the extract, 50, 100, 200 and 400 mg/kg. 
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Table 4.14: Suppressive anti-malarial activity of L. pumila leaves methanol extract 
 
Drug/extract Dose Parasitaemia% 
± S.E.M. (n=5) 
%Chemo 
suppression 
Control 0.2 mL 5.10 ± 0.33  
Leaves extract 50 mg/kg 4.10 ± 0.68 19.61 
  100 mg/kg 4.01 ± 1.04 21.33 
  200 mg/kg 3.10 ± 0.98 39.22 
  400 mg/kg 2.50 ± 0.63 50.94* 
Chloroquine 20 mg/kg 00.00 100 
* P ≤ 0.05 compared to the control group. 
 
 
 
 
 
 
Table 4.15: Curative anti-malarial activity of L. pumila leaves methanol extract 
 
 Extract/drug Dose Parasitaemia% 
(D6) 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 9.60 ± 0.93 
 
Leaves extract 50 mg/kg 9.40 ± 2.80 02.08 
 
100 mg/kg 8.20 ± 0.86 14.58 
 
200 mg/kg 7.40 ± 1.91 22.92 
 
400 mg/kg 5.00 ± 0.55 47.92 
Chloroquine 20 mg/kg 00.00 100 
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Figure 4.5: Comparison of parasitaemia chemosuppression of the L. pumila leaves 
extract-treated groups and control from D3 until D7 after infection 
 
 
 
 
Table 4.16: Mean survival time of mice treated with L. pumila leaves methanol extract 
 
Extract/drug Dose Mean survival time  
± S.E.M. (n=5) 
±  Control 0.2 mL 13.60 ± 0.51 
Leaves extract 50 mg/kg 13.20 ± 0.73 
 100 mg/kg 13.80 ± 1.11 
 200 mg/kg 14.40 ± 0.24 
 400 mg/kg 15.80 ± 1.39 
Chloroquine 20 mg/kg 27.20 ± 1.11* 
* P ≤ 0.05 compared to the control group. 
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Table 4.17: Prophylactic anti-malarial activity of L. pumila leaves methanol extract 
 
Extract/drug Dose Parasitaemia% 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 4.60 ± 0.51   
Leave extract 50 mg/kg 4.50 ± 0.59 02.17 
  100 mg/kg 4.00 ± 0.63 13.04 
  200 mg/kg 3.60 ± 0.93 21.74 
  400 mg/kg 2.90 ± 0.90 36.96 
Pyrimethamine 1.2 mg/kg 1.24 ± 0.47 73.04* 
* P ≤ 0.05 compared to the control group. 
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4.3.3 Languas galanga Stuntz. 
 
 
i. Phytochemical screening of L. galanga rhizome 
 
The presence of terpenoids, flavonoids, tannins, saponins, steroids and glycosides was 
indicated through the phytochemical screening of L. galanga rhizomes methanol 
extract. 
 
ii. Radical scavenging activity of L. galanga rhizome 
The methanol rhizome extract of L. galanga showed moderate DPPH radical 
scavenging activity. At 1.56–25 µg/mL, the scavenging abilities of the methanol extract 
were 10.08%, 8.63%, 15.64%, 29.34% and 37.88%, respectively, as shown in Figure 
4.6. At 25 µg/mL, ascorbic acid and gallic acid showed strong scavenging abilities 
reaching 72.74 and 73.79%, respectively.  
 
iii. Acute oral toxicity of L. galanga rhizome 
The mortality rates of orally administered L. galanga are shown in the Table 4.18. The 
most important observed behavioural indications of toxicity were asthenia, piloerection, 
ataxia, anorexia, urination, diarrhea, lethargy and coma. Asthenia, piloerection, 
anorexia, diarrhea and urination were noticed after dosing with 2,000 mg/kg and were 
more marked at the highest dose and continued until death, in particular among the male 
subjects, which showed a lethal median dose lower than that of the females. In ICR 
mice, the LD50 of L. galanga rhizome methanol extract was 4,998 mg/kg. 
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Figure 4.6:  DPPH scavenging % activity of L. galanga rhizomes methanol extract 
 
 
 
 
 
 
 
Table 4.18: Acute oral toxicity of L. galanga rhizome methanol extract in ICR mice 
 
Dose 
(mg/kg) 
Mortality        LD50  
Dead/tested mice Latency ( hour)   
0 0/10 -  
 
The median lethal dose 
determined by the 
probit analysis was 
4,998 mg/kg 
 
300 0/10 -  
2,000 1/10 >36, <60  
5,000 5/10 >24, <60  
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iv. Suppressive anti-malarial activity of L. galanga rhizome 
During early malaria infection, the rhizomes extract of L. galanga produced a dose 
dependent suppressive anti-malarial activity. The 4-day suppressive effects of 29.41%, 
49.02%, 62.55% and 64.51% were shown for the 50, 100, 200 and 400 mg/kg doses of 
the extract, respectively. After the 200 mg/kg, the anti-malarial activity of the extract 
showed only a marginal increase.  In the exception of the 50 mg/kg dose, the extract 
produced significant (P < 0.05) anti-malarial activity (Table 4.19).  
 
v. Curative anti-malarial activity of L. galanga rhizome 
 
In comparison with the control, L. galanga rhizome exhibited significant (P < 0.05) 
dose dependent curative anti-malarial activity. The parasitaemia percentages for the 
extract-treated groups on D6 of infection were 5.80%, 3.40%, 3.40% and 3.20% for 50, 
100, 200, and 400 mg/kg doses of the extract, respectively (Table 4.20). A marginal 
increase in the anti-malarial activity of the extract was exhibited over the 100 mg/kg 
dose. In Figure 4.7, parasitaemia chemosuppressions of the extracts groups and control 
from D3 until D7 after infection is exposed. The mean parasitaemia for the control 
group was 9.60. The mice group treated with the 200 and 400 mg/kg doses of the extract 
showed longer survival time, which was significantly different from the control group 
(Table 4.21).  
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Table 4.19: Suppressive anti-malarial activity of L. galanga rhizomes methanol extract 
 
Extract/drug Dose 
Parasitaemia% 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 5.10 ± 0.33  
Rhizome extract 50 mg/kg 3.60 ± 0.68 29.41 
  100 mg/kg 2.60 ± 0.37 49.02* 
  200 mg/kg 1.91 ± 0.91 62.55* 
  400 mg/kg 1.81 ± 0.89 64.51* 
Chloroquine 20 mg/kg 00.00 100 
* P ≤ 0.05 compared to the control group. 
 
 
Table 4.20: Curative anti-malarial activity of L. galanga rhizomes methanol extract 
 
Extract/drug Dose 
Parasitaemia% 
(D6) 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 9.60 ± 0.93  
Rhizome extract 50 mg/kg 5.80 ± 1.21 39.58 
 100 mg/kg 3.40 ± 0.22 64.58* 
 200 mg/kg 3.40 ± 0.78 65.58* 
 400 mg/kg 3.20 ± 0.77 66.67* 
Chloroquine 20 mg/kg 00.00 100 
* P ≤ 0.05 compared to the control group. 
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Figure 4.7: Comparison of parasitaemia chemosuppression of the L. galanga rhizomes 
extract-treated groups and control from D3 until D7 after infection 
 
 
 
 
Table 4.21: Mean survival time of mice treated with L. galanga rhizomes methanol 
extract 
 
Extract/drug Dose Mean survival time  
± S.E.M. (n=5) 
 Control 0.2 mL 13.60 ± 0.51 
Rhizome extract 50 mg/kg 14.40 ± 0.81 
 100 mg/kg 15.60 ± 0.98 
 200 mg/kg 17.60 ± 0.40* 
 400 mg/kg 18.00 ± 0.55* 
Chloroquine 20 mg/kg 27.20 ± 1.11* 
* P ≤ 0.05 compared to the control group. 
 
 
0 
2 
4 
6 
8 
10 
12 
14 
16 
D 3 D 4 D 5 D 6 D 7 
P
a
ra
si
ta
em
ia
 %
 
Days of obsevation 
Control 
400 mg/kg 
200 mg/kg 
100 mg/kg 
50 mg/kg 
 112 
 
vi. Prophylactic anti-malarial activity of L. galanga rhizome 
As summarized in Table 4.22, the results of prophylactic activity of the rhizomes extract 
during the residual malaria infection exhibited dose dependent suppression at the 50-
400 mg/kg doses, exerting 13.04%, 26.09%, 39.13% and 52.17% suppressions, 
respectively. It showed that though there were significant prophylactic activities at the 
doses with the highest concentrations (200 and 400 mg/kg), the chemosuppressive 
activity was rather low and not significant at the 100 and 50 mg/kg doses.  
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Table 4.22: Prophylactic anti-malarial activity of L. galanga rhizomes methanol extract 
 
Extract/drug Dose 
Parasitaemia% 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 mL 4.60 ± 0.51   
Rhizome extract 50 mg/kg 4.00 ± 0.55 13.04 
  100 mg/kg 3.40 ± 0.93 26.09 
  200 mg/kg 2.80 ± 0.49 39.13* 
  400 mg/kg 2.20 ± 0.37 52.17* 
Pyrimethamine 1.2 mg/kg 1.24 ± 0.47 73.04* 
* P ≤ 0.05 compared to the control group. 
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4.3.4 Piper betle L. 
 
i. Phytochemical screening of P. betle leaves 
Phytochemical screening of P. betle leaves methanol extract exposed that the leaf 
extract contains alkaloids, terpenoids, anthraquinones, flavonoids, tannins, saponins and 
steroids. 
 
ii. Radical scavenging activity of P. betle leaves 
P. betle leaves exhibited a strong radical scavenging capacity comparable to the 
controls. At the 12.5 µg/mL concentration of the methanol extract, the scavenging 
activity the leaves reached 82.56 ± 1.50 %, while at the same concentration, those of the 
ascorbic and gallic acids controls were 72.25 ± 2.44 and 73.03 ± 2.27 %, respectively 
(Figure 4.8).  
iii. Acute oral toxicity of P. betle leaves 
No deaths occurred during the observation period. Some signs were observed 1 hour 
following administration of the extract. Ataxia and piloerection were noted in males and 
females; all of which resolved by 3 hours after administration. No abnormal general 
signs were observed in the extract treated groups. All animals gained body weight on 
the end of the experiment, the tests and control groups did not show any significant 
differences (Table 4.23). 
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Figure 4.8:  DPPH scavenging % activity of P. betle leaves methanol extract 
 
 
Table 4.23: Body weight gain of mice receiving 5000 mg/kg of P. betle leaves methanol 
extract 
 
Mice groups Mean group weight (g) ± S.D. (g); n=5 
Mean 
weight gain 
(g); n=5 
 D-1 D0 D7 Day 14  
Control male 28.00 ± 1.11 
 
27.98 ± 1.28 30.52 ± 1.90 
 
31.80 ± 1.99 
 
3.80 ± 1.93 
 
 Test male 26.26 ± 0.77 
 
26.34 ± 0.82 
 
27.74 ± 2.35 
 
29.20 ± 2.72 
 
2.94 ± 1.39 
Control female 22.44 ± 0.42 
 
22.70 ± 0.37 
 
24.40 ± 1.07 
 
25.30 ± 0.72 
 
2.86 ± 1.37 
 
Test female 22.38 ± 1.31 
 
22.72 ± 1.21 
 
24.60 ± 1.31 
 
 
24.84 ± 3.05 
 
2.46 ±1.26 
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iv. Suppressive anti-malarial activity of P. betle leaves 
 
P. betle leaves methanol extract showed a dose-dependent chemosuppressive activity 
which ranged between 36.47% and 82.31% (Table 4.24). A significant high degree of 
chemosuppression was shown by the 200 and 400 mg/kg doses of the extract that 
reduced the parasitaemia of the infected mice when compared to control (P < 0.05). 
 
v. Curative antimalarial activity of P. betle leaves 
 
The results indicated that the methanol extract of P. betle leaves exhibited significant (P 
< 0.05) dose dependent chemosuppression in parasitaemia for all the extract doses in 
comparison with the control. A daily increases in parasitaemia reaching 9.60 % on D6 
of infection was exhibited by the control group (Figure 4.9). The chemosuppression 
effects for the treated groups on the D6 of infection were 37.50%, 45.83%, 66.46% and 
70.63% for the extract doses 50 to 400 mg/kg, respectively (Table 4.25). On the other 
hand, the mice extract-treated groups showed longer survival times reaching 19.00 ± 
1.22 days as compared to the control with 13.6 ± 0.51 days. The chloroquine-treated 
group had a mean survival time of 27.2 ± 2.33 days (Table 4.26).  
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Table 4.24: Suppressive anti-malarial activity of P. betle leaves methanol extract 
 
 Extract/drug Dose Parasitaemia% 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 ml 5.10 ± 0.33   
Leaves extract 50 mg/kg 3.24 ± 0.82 36.47 
  100 mg/kg 2.40 ± 0.68 52.94* 
  200 mg/kg 1.50 ± 0.63 70.51* 
  400 mg/kg 0.90 ± 0.33 82.31* 
Chloroquine 20 mg/kg 00.00 100 
* P ≤ 0.05 compared to the control group. 
 
 
 
 
 
 
Table 4.25: Curative anti-malarial activity of P. betle leaves methanol extract 
 
 Extract/drug Dose Parasitaemia% 
(D6) 
± S.E.M. (n=5) 
 
%Chemo-
suppression 
Control 0.2 ml 9.60 ± 0.93 
  
Leaves extract 50 mg/kg 6.00 ± 0.84 37.50* 
 
100 mg/kg 5.20 ± 0.92 45.83* 
 
200 mg/kg 3.22 ± 0.95 66.46* 
 
400 mg/kg 2.82 ± 0.84 70.63* 
Chloroquine 20 mg/kg 00.00 100 
* P ≤ 0.05 compared to the control group. 
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Figure 4.9: Comparison of parasitaemia chemosuppression of the P. betle leaves 
 extract-treated groups and control from D3 until D7 after infection 
 
 
 
 
Table 4.26: Mean survival time of mice treated with P. betle leaves methanol extract 
 
Drug/extract Dose 
Mean survival time  
± S.E.M. (n=5) 
 
Control 0.2 ml 13.60 ± 0.51 
Leaves extract 50 mg/kg 14.40 ± 0.93 
 
100 mg/kg 15.20 ± 1.16 
 
200 mg/kg 17.20 ± 1.56 
 
400 mg/kg 19.00 ± 1.22* 
Chloroquine 20 mg/kg 27.20 ± 2.33* 
* P ≤ 0.05 compared to the control group. 
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vi. Prophylactic anti-malarial activity of P. betle leaves 
 
The results of prophylactic activity of the leaves methanol extract of P. betle during the 
residual malaria infection exhibited significant (P < 0.05) dose dependent suppressions. 
The leaves extract exhibited 19.57, 34.78, 52.17 and 70.88% chemosuppressions, for the 
doses 50 to 400 mg/kg, respectively (Table 4.27). The chemosuppression shown by the 
400 mg/kg of the extract was comparable to the standard drug. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 120 
 
Table 4.27:  Prophylactic anti-malarial activity of P. betle leaves methanol extract 
 
Drug/extract Dose Parasitaemia% 
± S.E.M. (n=5) 
%Chemo-
suppression 
Control 0.2 ml 4.60 ± 0.51   
Leaves extract 50 mg/kg 3.70 ± 0.30 19.57 
  100 mg/kg 3.00 ± 1.34 34.78 
  200 mg/kg 2.20 ± 0.37 52.17* 
  400 mg/kg 1.34 ± 0.41 70.88* 
Pyrimethamine 1.2 mg/kg 1.24 ± 0.47 73.04* 
* P ≤ 0.05 compared to the control group. 
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CHAPTER V 
 
DISCUSSION 
 
5.1  COMMUNITY’S AWARENESS REGARDING MALARIA  
 
This study is the first to investigate the KAP on malaria in Peninsular Malaysia, which 
is directly essential to enhance community awareness of malaria. Findings of the present 
study indicated that there were significant differences between aboriginal and rural 
communities in knowledge and practices towards malaria transmission, treatment-
seeking behaviour and understanding of effective preventive measures. This could be 
explained by the better educational level and the higher number of health facilities 
reported among rural population. In addition, religious practices and cultural traditions 
among the inhabitants of remote areas may be the reason behind the inadequate 
knowledge of malaria. In general, Aborigines often attribute the illness to devil, ghosts 
or evil spirits. In this study, these practices either through the use of plants, consultation 
of traditional healers or sorcerers were demonstrated in about one third of the 
participants. 
 
 Moreover, most of the aboriginal people of this study live in houses made up of 
bamboo lacking of sanitation (APPENDIX A). There is poverty, malnutrition, high 
prevalence of intestinal parasitic infections (Al-Mekhlafi, 2008). Insufficient quality 
health care and poverty that are widespread among the aboriginal people can seriously 
hinder the elimination of malaria (WHO, 2005; Sharma, 2009).  
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 The present study also reported many mistaken beliefs about malaria particularly 
in the Aborigines where a large number of the participants demonstrated a 
misconception about its transmission. This emphasizes the need for effective 
interventions to improve the level of knowledge in this community. A noteworthy 
number of participants believed that malaria is transmitted by stagnant water, walking in 
forest, human to human via belongings and others. Although most of the participants 
associated malaria to mosquito bites, none of them knew that a parasite is the causative 
agent responsible for malaria neither how mosquitoes acquire the parasite. The role of 
mosquito vector in transmission of malaria was known to 50% and 70.7% of the 
aboriginal and rural participants, respectively. This figure was lower than that exhibited 
by respondents in a KAP study in Swaziland, Southern Africa (92.81%), a country 
earmarked for malaria elimination (Hlongwana et al., 2009).
 
Accordingly, it is clear that 
the lack of knowledge, among the target population, about the aetiology of the disease 
as well as the position of mosquitoes in causing malaria may add additional burden and 
costs for controlling the disease and may cause failure of malaria elimination 
programme.  
  
 Education plays an important role in people‘s perceptions and practices of 
treating and controlling malaria. Previous studies from Africa showed a positive 
correlation between the awareness of preventive measures to control malaria infection 
and the level of education among the community (Tarimo et al., 2000; Dike et al., 
2006). Furthermore, the use of medicinal plants to combat malaria was lower in people 
who have a higher level of formal education (Dike et al., 2006). In harmony with these 
findings, the present study showed that the better educational level of the rural 
community reflected a better knowledge and practices regarding malaria prevention and 
treatment than the aboriginal people. At the community level, the level of education 
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showed a significant impact on population‘s Knowledge, attitudes and practices on 
malaria. 
 
 The findings of this study showed that most people in both communities had 
information about symptoms of malaria and more than three quarters of the participants 
recognized fever, chills/rigors and headache as most common symptoms. This was in 
agreement with the previous studies in tropical and subtropical malaria endemic 
countries (Simsek & Kurcer, 2005; Swe & Pearson, 2004). It should be noted that a 
considerable number of participants in both communities showed confusion between the 
symptoms of malaria and dengue fever which is also endemic in these areas. However, 
this may not affect the disease control in terms of the mosquito control but, it may lead 
to serious complications in patients who believe that dengue fever can be cured by 
taking anti-pyretics and drinking fluids (Nalongsack et al., 2009). 
 
 Promising results about treatment-seeking behaviour were reported; almost all 
the rural participants and two thirds of the aboriginal participants seek treatment at 
health centers within twenty-four hours of the symptoms onset. Previous studies in rural 
areas in Southeast Asia showed that more than half of the population opts for self-
treatment without visiting a health facility (Sanjana et al., 2006; Joshi & Banjara, 2008). 
The better behaviour reported by the present study could be due to the availability of 
health facilities and access to its services by all Malaysians throughout the country. 
Most of the aboriginal people who use medicinal plants and believe in witchcraft as a 
treatment for febrile diseases go to health centres for treatment, either within 24 hours 
exercising this practice to support the modern treatment or within 48-72 hours after 
waiting for the outcome of traditional recipes for a short period of time and then seek 
treatment from health centres. Of reasons not to seek treatment on the first day of the 
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onset of fever is to wait until the disease worsened to the belief that febrile diseases 
resolve spontaneously (Nyamongo, 2002). 
 
 Regarding the understanding of the measures for the prevention of malaria, the 
present study showed that most of the participants were aware that malaria can be 
prevented. However, many misconceptions about malaria prevention measures were 
reported. In both communities, more than one third of the participants do not use bed 
nets to prevent mosquito bites. This could be due to the reliance of these populations on 
the government in fighting the disease without taking enough personal precautions. The 
poor usage of mosquito bed nets might also be attributed to the cost and to the lack of 
knowledge that mosquitoes are the causative agents of malaria (Minja et al., 2001; 
Oguonua et al., 2005).  
 
 The comparison between the forest-aboriginal and rural communities has a great 
benefit to determine the nature of adaptations required in the plan of future 
interventions. Public awareness programmes to promote a better understanding on 
malaria transmission and active participation of the aboriginal communities in malaria 
control activities are deemed necessary. Such awareness and participation will bring 
positive changes and adaptation in their cultural beliefs and practices and this can help 
in reducing the incidence of malaria. 
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5.2 ETHNOBOTANICAL STUDY ON ANTI-MALARIAL PLANTS 
 
The present survey has established a preliminary data base for 19 species of plant 
species used to combat malaria in Malaysia that are essential for further phytochemical 
and pharmaceutical studies. The obtained data has also revealed how different 
interviewed groups are able to enrich the information about the used plants in 
combating malaria. The majority of the species preferred by the traditional healers were 
considered to be active by the respondents, which suggests, in agreement with Asase et 
al. (2005), that traditional healers possessed a high knowledge of the medicinal plants. 
 
Seven plant species namely, Alstonia angustiloba, Brucea javanica, Cassia 
siamea, Phyllanthus niruri, Eurycoma longofolia, Languas galanga and Tinospora 
crispa recorded in this survey are used in East Malaysia to treat malaria, Kamarudin 
(1997), Kulip (1997), Fasihuddin (2000) and Fasihuddin & Holdsworth (2003) while 
the anti-malarial use of the other 12 plant species in West Malaysia were identified and 
documented for the first time.  
 
Drinking the extract decoction was the most reported preparation regarding the 
use of the plant remedies among the population in fight against the disease. However, 
the accurate quantity, standardization and quality control of the using the remedies were 
generally indistinguishable. The absent of quality control and standardization is seemed 
to be one of the major weaknesses of traditional medicine (Asase et al., 2005). 
Moreover, the combination in the traditional remedies causes further difficulty 
regarding regulation, evaluation and observation of the degrees of biologically active 
ingredients (Asase et al., 2005). 
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5.3 ANTI-MALARIAL ACTIVITY OF THE PLANTS EXTRACTS 
 
 
 
Anti-malarial activity screening tests of C.nucifera, L.pumila, L.galanga and P.betle 
showed that each of the four plant extracts exhibited active malaria suppression activity 
of more than 30% against P.berghei infection in mice as evident from the degree of 
suppressions obtained based on the 4-day suppressive tests (Krettli et al., 2009).  
 
 
 The chemosuppressions activity showed to be dose dependent where higher 
concentrations of the doses caused higher degree of anti-malarial chemosuppression 
activity (Figure 5.1). L.pumila showed a clear increase proportionately among all the 
extract doses in all the anti-malarial tests. By increasing extract dose a clear increase in 
activity was observed, suggesting that more increases in the concentration showed 
further increases in the activity. On the other hand, marginal increases in activity of L. 
galanga over 100 mg/kg was observed by the 200 and 400 mg/kg doses in both 
suppressive as well as curative assays suggesting that additional increases in the 
concentration resulted in merely marginal increases in suppression (Elufioye & 
Agbedahunsi, 2004), that may represents the maximum concentration by which the anti-
malarial molecules included in the extract can affect the parasite. C.nucifera exhibited 
marginal increases by the 400 mg/kg in both suppressive and curative assays. However, 
P.betle showed a slight marginal increase by the 400 mg/kg in curative assay, which 
may indicate that this plant can exhibit higher anti-malarial effects by increasing the 
dose concentrations.  
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Figure 5.1: The in vivo anti-malarial effects of the plants extract 
 
 
 
Figure 5.2: The mean survival time of the plants extract  
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 The extracts also exhibited a curative activity with significant (P< 0.05) high 
mean survival time values during the established malaria infection particularly in the 
groups administered with P.betle and L.galanga (Figure 5.2). Overall results with 
evident of increasing the mean survival time showed that P.betle and L.galanga were 
the most effective followed by C.nucifera and L.pumila, respectively. Although 
C.nucifera caused high degrees of suppression comparable to P.betle in all the three 
assessment models, but the increment in the survival time of the infected mice was not 
significant. These activities can be interpret as a result of individual effect by one of the 
chemical constituents included in C.nucifera and most important of which are 
terpenoids. This finding could be very important for further investigation of these 
compounds individually. The second possibility is a promising immunomodulatory 
effect that this plant (C.nucifera) may possess, which as  a concern may give impression 
on the host-parasite interrelationship (Anthony et al., 2005).  Moreover, coconut oil is 
rich in fatty acid with more than 40% of the total fatty acids is lauric acid (Azeez, 
2007). A previous study reported that injection of fatty acids during the first three days 
after infection protected mice infected with P. berghei from cerebral symptoms and 
increased the survival time (Moumaris et al., 1995). A possible immunoregulatory role 
for fatty acids which enhances neutrophil-mediated killing of P. falciparum has been 
also identified (Kumaratilake et al., 1997). 
 
 When standard anti-malarial drug chloroquine (20 mg/kg body weight) is used 
to cure mice infected with P. berghei, it suppressed parasitaemia to non-detectable 
levels (Ishih et al., 2006; Muregi et al., 2007), which is also evident in this study. 
However, it was shown that the dose that we used in curative tests did not cure all the 
animals. The developed resistance may be as a result of the repeated passage of the 
parasite in the mice in the context of maintaining the strain in the laboratory (Adzu, et 
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al., 2003; Chawira, 1986; Okokon, et al., 2005). Conversely, the parasitaemia 
suppression pyrimethamine at 1.2 mg/kg seemed to be in agreement with previous 
studies conducted on the repository activity in P. berghei infected mice (Elufioye & 
Agbedahunsi, 2004; Chandel & Bagai, 2010). 
 
 The present study also showed that the test extracts are toxicologically safe by 
oral administration. In GHS classification: Health Effects Test Guidelines, the LD50 
value exceeding than 5000 mg/kg showed by C.nucifera, L.pumila and P.betle extracts 
are practically safe (Horn, 1956; GHS, 2005; Rhiouani et al., 2008). On the other hand, 
the acute oral toxicity (LD50) of L. galanga of 4,998 mg/kg is also safe according to 
Horn (1956) and Rhiouani et al. (2008), who stated that ―plants or plant products with 
LD50 values higher than 2,000–3,000 mg/kg are considered free of any toxicity‖. This 
supports the logical usage of these plants in folk medicine practices. 
 
 The present study had followed a logical pathway in the extraction procedures 
by using the methanol solvent as an extractor. Because most of the identified anti-
microorganisms aromatic and saturated organic compounds of plant components were 
acquired during the preliminary methanol extraction (Fransworth, 1994; Eloff ,1998; 
Cowan ,1999; Reuben et al., 2008; Usman et al., 2009;  Peni et al., 2010; 
Karthishwaran et al., 2010).  
 
 The anti-plasmodial activities revealed by the plants were perhaps as a result of 
active chemical ingredients. Phytochemical screening of the plants methanol extracts 
exposed the presence of alkaloids, terpenoids, anthraquinones, flavonoids, tannins, 
saponins, glycosides and steroids.  
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 Those chemical components however can differ in their potentials in causing 
effective malaria suppression. Those differences are depending on the active molecules 
involved in the reaction against the parasites. For example, the alkaloids and terpenoids 
isolated from Cinchona species and Artemisia annua, respectively, have different 
activity than those isolated from other plants. Therefore, it is very possible that each 
chemical constituent might has a special characteristic and different structural classes.   
 
 Alkaloids are important members of chemical constituents having anti-malarial 
activity. In a review article by Saxena et al. (2003), one hundred alkaloids from 
medicinal plants were accounted to reveal important anti-malarial effects in reports 
published between 1990 and 2003; some of these alkaloids exhibited anti-malarial 
activity more than chloroquine. Bisbenzylisoquinolines, Aporphine-benzylisoquinoline, 
Morphinan, Naphtylisoquinolines, an Indoloquinoline , Mono- and bis-indole alkaloids, 
Indolomonoterpenoid, Indole, Benzofenantridine, Acridone, Furoquinoline, Acridine, 
Tetrahydroquinoline are some of the active anti-malarial alkaloids reported of different 
structural classes isolated from plant sources (Oliveira et al., 2009b). Meanwhile, 
Icajine, Vomicine, Isostrychnine, Cryptolepine, berberine , palmatine , jatrorrhizine  and 
several berberine alkaloids derivatives showed  inactive anti-malarial activity  in vivo 
(Vennerstrom & Klayman, 1988; Federici et al., 2000; Frederich et al., 2000). 
 
 Many structural classes of terpenoids exhibited potent anti-malarial activity. Of 
these are keberins and friedelane triterpenoid, indanone derivative, cassane-type 
diterpenes, furanoterpenoids, monoterpenes geraniol and monoterpenoids; (-)-linalool, 
(-)-perillyl alcohol, (-)-isopulegol (-)-limonene and (±)-citronellol (Batista et al., 2009). 
Examples of common terpenoids are farnesol and artemisinin (sesquiterpenoids). 
Artemisinin and related derivatives are the most vital new member  of anti-malarial 
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structural classes, which are developed from Artemisia annua plant in China beginning 
in the 1960s (Philip & Rosenthal, 2008). Terpenoids are also have anti-bacterial effects 
(Ahmed et al., 1993; Mendoza et al., 1997; Amaral et al., 1998; Singh & Singh 2003; 
Souza et al., 2010) anti-fungal (Harrigan et al., 1993; Ayafor et al., 1994; Suresh et al., 
1997; Singh & Singh 2003) anti-viral (Fujioka & Kashiwada, 1994; Xu et al., 1996) and 
anti-protozoal (Vishwakarma, 1990; Francois et al., 1996; Ghoshal et al., 1996; 
Delgado-Méndez et al., 2008). 
 
 Flavonoids are phenolic structures synthesized by plants in response to microbial 
infections. Flavonoids exposed significant anti-parasitic activities against different 
strains of Plasmodium species, trypanosome and leishmania (Kim et al., 2004; 
Monbrison et al., 2006; Tasdemir et al., 2006; Khaomek et al., 2008; dos Santos et al., 
2009). The anti-malarial activities of flavonoids have not been expressed in the past, 
while they represent one of the most distinctive compounds in higher plants. Artemisia 
annua flavonoids were not exhibited effective anti-malarial activity (Liu et al., 1992).  
 
 The results of the phytochemical screening also showed that P. betle leaves 
extract contained anthraquinones.  These chemical compounds are an important member 
of the quinone family. Many naturally-occurring quinones are based in their structure on 
the anthraquinone, naphthoquinone or benzoquinone ring system. Derivatives of 9,10-
anthraquinone include many important drugs including anti-malarials like rufigallol 
(Mahajan et al.,  2005). Different classes of anthraquinones showed significant anti-
malarial activities in the recent concerned studies. A novel anti-malarial anthraquinone 
named anthrakunthone from the root bark of Stereospermum kunthianum was isolated 
(Onegi et al., 2002). The bark of Scutia myrtina (Rhamnaceae) led to the isolation of 
three new anthraquinones named scutianthraquinones A, B and C. These 
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anthraquinones compounds exhibited significant anti-plasmodial activities (Hou et al., 
2009). 
 
 Saponins are a class of chemical constituents found in various plant species that 
can affect Plasmodium parasite. Philipson & Wright (1991) stated that plants having 
phytochemical compounds include saponins may have anti-malarial activities. In 1996, 
Okunji et al. isolated saponin spiroconazole A from Dracaena species that revealed 
pronounced anti-leishmanial, anti-malarial and molluscicidal activities. Study by Nandi 
et al. (2004) suggested that saponins can generate superoxide anions and initiate lipid 
peroxidation in a mechanism to kill the Plasmodium parasite. 
 
 A new steroidal glycoside, gongroneside A which has been isolated from the 
vine of Gongronema napalense (Wall.) Decne. (Asclepiadaceae) exhibited promising 
anti-malarial activity (Libman et al., 2008) as well as amino steroids 8d showed potent 
anti-plasmodial inhibition (Sharma et al., 2008). Tannin-rich fractions from Punica 
granatum L.  exposed promising anti-plasmodial and anti-microbial activity (Reddy et 
al., 2007). 
 
 It seems that the phytochemical screening showed that the plant extracts contain 
some vital chemical constituents which may exert the observed anti-plasmodial activity. 
These chemical constituents could be acting separately or in combination with one 
another (synergic action).  P. betle consisted most of these chemical constituents 
followed by L. galanga, L. pumila and C. nucifera, respectively (Table 5.1). 
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Table 5.1: The active chemical constituents found in the plants extract 
 
 C. nucifera L. pumila L. galanga P. betle 
Alkaloids - -  - + 
Terpenoids + + + + 
Flavonoids - + + + 
Anthraquinones - - - + 
Tannin + + + + 
Steroids + + + + 
Saponins - + + + 
Glycosides + - + - 
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 The antioxidant effect of the plant extracts can represent a further system that 
plays a role against the malaria parasite. P. betle showed the highest antioxidant 
capacity followed by L. pumila and L. galanga. C. nucifera exhibited a weak DPPH 
scavenging % activity. The potent antioxidant capacity exhibited by the P. betle leaves 
maybe as a result of the phenolic compounds in the leaves, such as chavicol, chavibetol, 
chavibetol acetate and eugenol (Amonkar et al., 1986; Rimando et al., 1986; 
Nagabhushan et al., 1989).  
 
 Reactive oxygen species are produced due to stimulation of immune system by 
malaria infection resulting in haemoglobin degradation (Das & Nanada, 1999; Loria et 
al., 1999). Rhizomes extract of L. galanga, leaves extract of P. betle showed nitric 
oxide (NO) production inhibitory activities in mouse and rat peritoneal macrophages 
(Morikawa et al., 2005; Ganguly et al., 2007), respectively. Nitric oxide (NO) is an 
effective mechanism to kill parasites, which is produced in macrophages in response to 
parasitic infection, which in turn activates the immune response against malaria 
(Daubener, 1999). Therefore, the inhibition of NO by the extract helps in preparing 
good surroundings to development of intracellular parasite. On the other hand, these 
inhibition cause a decrease in an essential amino acid, tryptophan, which undergo to 
degradation through indolamine deoxygenase. Hence, the parasite is starved leading to 
its death (Daubener, 1999; Anthony et al., 2005). Recently, it was observed that there is 
a good correlation between potential DPPH radical scavenging activity and anti-malarial 
activity of Argan fruit extracts (El Babili et al., 2010). 
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 A further anti-inflammatory effect of plants extracts may be hepatoprotective 
during the early stage of infection. For example, the anti-inflammatory effect of Nigella 
sativa (Al-Ghamdi, 2001) reported to be hepatoprotective in mice (Turkdogan et al., 
2001). It revealed a protective role against chromosomal aberrations in Schistosoma 
mansoni infection (Mahmoud et al., 2002). This mechanism may afford protection in 
malaria infection by reducing inflammation during the early hepatic stage of infection. 
Anti-inflammatory effects of C.nucifera, L.pumila, L.galanga and P.betle were reported 
by Intahphuak et al. (2010), Ikujuni et al. (2010), Chudiwal et al. (2010) and Ganguly et 
al. (2007), respectively.  
 
 Anti-pyretic effects of plants may be the reason attributed to the use of the plant 
to control fever. Virgin coconut oil showed an anti-pyretic effect in yeast-induced 
hyperthermia (Intahphuak et al., 2010). 100 mg/kg of L. pumila leaves exhibited 
significant anti-pyretic activity in rat (Ikujuni et al., 2010).  The juice of the leaves of P. 
betle is used as anti-pyretic agent (Choudhury et al., 2010).  
 
 Finally, our results are in agreement with others who showed that C. nucifera 
white flesh oil, L. pumila leaves, L. galanga rhizome and P. betle leaves extracts 
possess anti-microbial activities (Table 5.2). The anti-malarial activity presented in this 
research may be as a result of a separate or combined action of the mechanisms 
discussed above.  However, the responsible principles are yet to be recognized, which 
require advanced studies to reveal the anti-plasmodial mechanisms of their actions. 
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Table 5.2: Anti-microbial activities of the plants extract existing in the literature 
 
 
 
Table 5.2 continued:  Anti-microbial activities of the plants extract existing in the 
literature 
 
 
 
 
 
 
 
 
 
Anti-fungal  Anti-parasitic  
C. nucifera  (Jolaoso et al., 2010)  
L. pumila   Ibrahim  et al. (2003) 
L. galanga  (Janssen & Scheffer, 1985) Anti-trypanosomal (Nahoko, 2009), 
Anti-leishmanial (Amandeep et al., 
2010) and anti-helmithic (Raj, 
1975; Nahoko, 2009; Amandeep et 
al., 2010). 
P. betle  (Trakranrungsie et al., 2006) Anti-leishmanial (Avijit et al., 
2008), Anti-filarial (Singh et al., 
2009) 
 
Anti-bacterial Anti-viral 
C. nucifera  (Jolaoso et al., 2010) and 
 (Oyi et al., 2010). 
 
L. pumila  (Fasihuddin et al., 1995)  
L. galanga  (Oonmetta-aree et al., 2006) (Ye & Li, 2006) 
P. betle  (Nalina & Rahim, 2007)  
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CHAPTER VI 
 
CONCLUSION AND RECOMMENDATIONS 
 
6.1 CONCLUSION 
 
In spite of the permanent attempts by the government and private sectors, malaria is still 
a serious disease threatening millions of people around the world. Currently, the 
emergence of Plasmodium species resistant to almost all available anti-malarial drugs 
has become a vital challenge in malaria control efforts.  
 
The success in combating malaria absolutely depends on combination of various 
methods such as IRS of insecticides and biological methods. The elimination of malaria 
from a community however requires several other measures including improvement on 
the awareness of community regarding the disease, which can greatly increase the 
realization and sustainability of malaria elimination programmes. In addition, 
considering the growing anti-malarial drug resistance problem, there is also a call for 
arise novel anti-malarial agents to cope with the spread of resistant malaria parasites.  
Traditional medicinal plants had proved to be one of the most important sources of the 
new anti-malarial agents.  
 
This research was carried out to study the community‘s awareness regarding 
malaria and establish a preliminary ethnobotanical database for the plants traditionally 
used to treat malaria among aboriginal and rural communities, and traditional healers in 
malaria endemic areas in Pahang, Malaysia. Acute oral toxicity, phytochemical 
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screening, anti-oxidant capacity and in vivo anti-malarial activity of C. nucifera white 
flesh, L. pumila leaves, L. galanga rhizome and P. betle leaves selected based on the 
ethnobotanical survey were investigated. 
 
 This study revealed that the aboriginal and rural communities have shown 
awareness of malaria as a disease, however knowledge about transmission and 
prevention of malaria is inadequate, in particular, among the aboriginal population and 
this could be a challenging obstacle to the elimination of malaria from Malaysia. This 
figure was lower than that reported in another countries earmarked for malaria 
elimination. Hence, malaria elimination programme should consider health education 
and community participation will enhance prevention and instil better knowledge on 
malaria transmission and prevention. Accordingly, the findings of this survey would 
assist the health authorities to create a concept of malaria KAP of the target community, 
to use efficient tools for health education and to improve and sustain good practices for 
malaria prevention. 
 
 The ethnobotanical data reported in this research provided an 
ethnopharmacological database for further anti-malarial phytochemical and 
pharmaceutical studies. The literature search results showed that most of the plants used 
by indigenous Malaysians have been tested against malaria in different parts of the 
world and have shown significant results. These studies support the Malaysian 
traditional medicinal plants to be based on pharmacological basis.  
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 The methanol extracts of C. nucifera, L. galanga and P. betle demonstrated 
significant (P < 0.05) anti-plasmodial activity during the suppressive, curative and 
prophylactic assays of the anti-malarial evaluations. The L. pumila extract showed 
significant results only in the early malaria infection at the 400 mg/kg, the highest 
concentration of the extract.  In addition, L. pumila and P. betle exhibited clear dose-
dependent chemosuppressions activities in all the three models of the anti-malarial 
evaluations, which may indicate that these plants can exhibit higher and more 
significant anti-malarial effects by increasing the dose concentrations.  
 
 The phytochemical screening showed that the plants extract contains some vital 
chemical constituents which may exert the observed anti-malarial activity. These 
chemical constituents could be acting separately or in combination with one another 
(synergic action). Anti-oxidant, immunomodulatory, inflammatory and anti-pyretic 
effects may represent the mechanisms that contribute to their anti-malarial activity. The 
anti-plasmodial activity presented in this research may be as a result of a separate or 
collective action of these effects. 
 
 Finally, it is anticipated that the results arising from this work that had been 
published in national and international journals (ISI/SCOPUS Cited Publication) would 
stimulate further research on these plants in the future. This study also confirms that the 
Malaysian folkloric medicinal application of the plants has a pharmacological basis. 
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The following are the findings of this study: 
 
1. Most of the respondents in the aboriginal and rural areas have knowledge of 
malaria as a disease. Overall, the rural participants showed significantly higher 
knowledge about malaria transmission than the Aborigines and this was found to 
be influenced by their level of education. Fever was the dominant symptom 
attributed to malaria followed by chills, rigors and headache. There was no 
significant difference between the aboriginal and rural regarding the attitude 
towards seriousness of the disease.  
 
2. Promising results about treatment-seeking behaviour were reported; almost all 
the rural participants and two thirds of the aboriginal participants seek treatment 
at health centres within twenty-four hours of the symptoms onset. Most of the 
aboriginal people who use medicinal plants and witchcraft as a first line activity 
go to health centres for treatment within two-three days. Of the 223 interviewed 
respondents, 28% and 15.4% of the aboriginal and rural respondents respectively 
had tried self medication with anti-malarial plant remedies to cure malaria or 
fever, respectively. 
 
3. Elimination of mosquito breeding areas and using of insecticides as preventive 
measures practices to combat malaria were significantly higher in the rural 
community. No significant difference between the rural and aboriginal 
communities regarding the use of mosquito bed nets. 
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4. A total of 19 species in 17 families used to treat malaria or fever were identified. 
Twelve plant species were identified and documented for the first time. The 
most frequent method of treatment was oral administration of decoctions or 
infusions (15 of 19 plants) and 4 plants were applied externally.  
 
5. C. nucifera white flesh extract contained some phytochemical constituents and is 
toxicologically safe by oral administration. By the 200 and 400 mg/kg doses, the 
extract significantly reduced the parasitaemia in the all three in vivo assessment 
assays. However, the extract did not significantly increase the survival time of 
the infected mice. 
 
6. L. pumila leave methanol extract is toxicologically safe by oral administration 
and demonstrated active anti-malarial activity during the suppressive, curative and 
prophylactic assays of the anti-malarial evaluations. During the early malaria 
infection the 400 mg/kg showed significant anti-malarial suppression. However, 
the extract did not significantly either reduce the parasitaemia or increase the 
survival time of the infected mice during the established and residual infections. 
The extract also showed a moderate DPPH scavenging % activity and contained 
some phytochemical constituents. 
 
7. L. galanga rhizomes methanol extract contained some phytochemical 
constituents and is toxicologically safe by oral administration. The extract 
demonstrated significant anti-plasmodial effects by the 200 and 400 mg/kg 
concentrations in all the three models of the anti-malarial evaluations and 
increased the survival time of the infected. The extract revealed the presence of 
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some phytochemical constituents and showed a moderate DPPH scavenging % 
activity.  
 
8. P. betle exhibited a potent anti-oxidant ability to scavenge the free radicals, 
toxicologically safe by oral administration and contained some phytochemical 
constituents. The extract demonstrated significant anti-malarial activity during 
the suppressive, curative and prophylactic assays of the anti-malarial evaluations.  
 
9. Overall results of the in vivo anti-malarial activity of the methanol extract of 
C.nucifera, L.pumila, L.galanga and P.betle during early, established and 
residual malaria infections with evidence of increasing mean survival time of the 
infected mice showed that P.betle and L.galanga were the most effective 
followed by C.nucifera and L.pumila, respectively. 
 
10. The results suggest that the Malaysian folkloric medicinal application of P.betle, 
L.galanga, C.nucifera and L.pumila has a pharmacological basis. The extract 
reduced parasitaemia but it cannot be considered a cure for malaria. 
 
6.2 LIMITATIONS 
 
In this present study, few limitations were encountered throughout the duration 
of the experiments. The ethnobotanical survey took longer than expected, partly 
due to the process of identification of plants which need specific international 
standard requirements.  
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6.3  RECOMMENDATIONS 
 
The following are the recommendations based on findings of this project: 
 
1. Using efficient tools for health education and to improve and sustain good 
practices for malaria prevention in order to eliminate or at least to contain this 
serious health problem. 
 
2. Establishment of an integrated development plan for aboriginal people which 
include health, social and intellectual rehabilitation. 
 
3. Further ethnobotanical surveys in the Malaysian states endemic for malaria to 
enrich the documentation of plants used against malaria, and to give priority to 
those plants to be investigated for their activities against the parasite. 
 
4. Regulate the alternative medicine and Witchcraft. 
 
5. Identification and isolation of the bioactive principles present in the plants 
extract, in particular, C. nucifera, L. galanga and P. betle could results in 
potential anti-malarial agents. 
 
6. Further studies on the plants extract in combination with current anti-malarial 
drug such as chloroquine could reveal good results. 
 
7. Further anti-malarial studies on the plants extract using Plasmodium species that 
affect human beings are recommended. 
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